{"content":"<li class=\"n-box-item date-title\" data-end=\"1549083599\" data-start=\"1548997200\" data-txt=\"Monday, December 23, 2019\">Friday, February  1, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3428866\" data-ts=\"1549061605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCC\" target=\"_blank\">MCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428866-mcc-eght-mfin-and-elli-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MCC, EGHT, MFIN and ELLI among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/MCC' title='Medley Capital'>MCC</a> <font color=\"green\">+15.4%</font>. <a href='https://seekingalpha.com/symbol/ELLI' title='Ellie Mae, Inc.'>ELLI</a> <font color=\"green\">+5.9%</font>. <a href='https://seekingalpha.com/symbol/CDXS' title='Codexis, Inc.'>CDXS</a> <font color=\"green\">+5.6%</font>. <a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a> <font color=\"green\">+4.8%</font>. <a href='https://seekingalpha.com/symbol/SUM' title='Summit Materials'>SUM</a> <font color=\"green\">+1.7%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/MFIN' title='Medallion Financial'>MFIN</a> <font color=\"red\">-20%</font>. <a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a> <font color=\"red\">-3.8%</font>. <a href='https://seekingalpha.com/symbol/HAYN' title='Haynes International, Inc.'>HAYN</a> <font color=\"red\">-2.7%</font>. <a href='https://seekingalpha.com/symbol/EGHT' title='8X8 Inc'>EGHT</a> <font color=\"red\">-1.9%</font>. <a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a> <font color=\"red\">-1.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428866\" data-linked=\"MCC, EGHT, MFIN and ELLI among notable after hour movers\" data-tweet=\"$MCC $MCC $ELLI - MCC, EGHT, MFIN and ELLI among notable after hour movers https://seekingalpha.com/news/3428866-mcc-eght-mfin-and-elli-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428866-mcc-eght-mfin-and-elli-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428853\" data-ts=\"1549058774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EOLS\" target=\"_blank\">EOLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428853-fda-oks-evolus-jeuveau-for-frown-lines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs Evolus&#39; Jeuveau for frown lines</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17399568-evolus-receives-fda-approval-jeuveau-prabotulinumtoxina-xvfs-injection\" target=\"_blank\">approves </a>Evolus' (NASDAQ:<a href='https://seekingalpha.com/symbol/EOLS' title='Evolus, Inc.'>EOLS</a>) Jeuveau (prabotulinumtoxinA) for the temporary improvement in the appearance of moderate-to-severe glabellar (frown) lines. The product is a direct competitor to Allergan's (NYSE:<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>) Botox.</li><li>Market launch should commence this Spring.</li><li>Shares, currently halted, will resume trading at 5:30 pm ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428853\" data-linked=\"FDA OKs Evolus&#39; Jeuveau for frown lines\" data-tweet=\"$EOLS $EOLS $AGN - FDA OKs Evolus&#39; Jeuveau for frown lines https://seekingalpha.com/news/3428853-fda-oks-evolus-jeuveau-for-frown-lines?source=tweet\" data-url=\"https://seekingalpha.com/news/3428853-fda-oks-evolus-jeuveau-for-frown-lines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428845\" data-ts=\"1549057435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTX\" target=\"_blank\">CYTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428845-cytori-files-for-equity-offering-shares-down-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytori files for equity offering; shares down 6% after hours</a></h4><ul><li>Cytori Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1095981/000156459019001699/cytx-s1.htm\" target=\"_blank\">prospectus </a>for an unspecified public offering of Class A and Class B Units.</li><li>Each Class A Unit consists of one share of common stock and one Series U warrant to purchase 1/2 of a common share.</li><li>Each Class B Unit consists of one Series D Preferred Share and warrants to purchase common shares.</li><li>Prices, volumes and terms have yet to be announced.</li><li>Shares are down <font color=\"red\">6%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428845\" data-linked=\"Cytori files for equity offering; shares down 6% after hours\" data-tweet=\"$CYTX $PSTV - Cytori files for equity offering; shares down 6% after hours https://seekingalpha.com/news/3428845-cytori-files-for-equity-offering-shares-down-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3428845-cytori-files-for-equity-offering-shares-down-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428820\" data-ts=\"1549055415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALKS\" target=\"_blank\">ALKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428820-fda-rejects-alkermes-nda-for-antidepressant-alks-5461-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA rejects Alkermes&#39; NDA for antidepressant ALKS 5461; shares down 4% after hours</a></h4><ul><li>Alkermes plc (NASDAQ:<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a>) has <a href=\"https://seekingalpha.com/pr/17399484-alkermes-receives-complete-response-letter-u-s-food-drug-administration-alks-5461-new-drug\" target=\"_blank\">received a CRL</a> in response to its marketing application seeking approval for ALKS 5461 for the adjunctive treatment of major depressive disorder &#40;MDD&#41;.</li><li>The CRL cited the need for additional clinical data to prove its effectiveness.</li><li>The company plans to meet with the agency to clarify a path forward.</li><li>In April 2018, it received a Refusal to File letter from the FDA in response to its initial filing, meaning that the application was not complete enough to review.</li><li>Shares are down <font color=\"red\">4%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3342847-fda-rejects-alkermes-marketing-application-mdd-med-alks-5461\" target=\"_blank\">FDA rejects Alkermes' marketing application for MDD med ALKS 5461</a> (April 2, 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428820\" data-linked=\"FDA rejects Alkermes&#39; NDA for antidepressant ALKS 5461; shares down 4% after hours\" data-tweet=\"$ALKS - FDA rejects Alkermes&#39; NDA for antidepressant ALKS 5461; shares down 4% after hours https://seekingalpha.com/news/3428820-fda-rejects-alkermes-nda-for-antidepressant-alks-5461-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3428820-fda-rejects-alkermes-nda-for-antidepressant-alks-5461-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428811\" data-ts=\"1549054501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITW\" target=\"_blank\">ITW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428811-illinois-tool-worksminus-2-after-mixed-q4-downside-q1-earnings-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Illinois Tool Works -2% after mixed Q4, downside Q1 earnings guidance</a></h4><ul><li>Illinois Tool Works (<a href='https://seekingalpha.com/symbol/ITW' title='Illinois Tool Works Inc.'>ITW</a> <font color='red'>-2.3%</font>) slides after reporting mixed <a href=\"https://seekingalpha.com/news/3428587-illinois-tool-works-beats-0_01-misses-revenue\" target=\"_blank\">Q4 results</a> and guiding Q1 earnings <a href=\"https://www.marketwatch.com/story/illinois-tool-works-shares-slump-as-guidance-falls-short-of-estimates-2019-02-01\" target=\"_blank\">below Wall Street expectations</a>.</li><li>ITW says it expects Q1 EPS of $1.73-$1.83 - including an increased $0.07 estimated restructuring cost, $0.07 forex currency translation effect and a tax rate that represents another $0.05 headwind - vs. $1.94 analyst consensus estimate, and reaffirms FY 2019 EPS guidance of $7.90-$8.20 vs. $8.02 analyst consensus.</li><li>Q4 revenue came in flat at $3.6B, as 1% organic growth was more than offset by the impact of foreign currency translation; full-year revenue rose 3% to $14.8B, with organic growth of 2%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428811\" data-linked=\"Illinois Tool Works -2% after mixed Q4, downside Q1 earnings guidance\" data-tweet=\"$ITW - Illinois Tool Works -2% after mixed Q4, downside Q1 earnings guidance https://seekingalpha.com/news/3428811-illinois-tool-worksminus-2-after-mixed-q4-downside-q1-earnings-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3428811-illinois-tool-worksminus-2-after-mixed-q4-downside-q1-earnings-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428807\" data-ts=\"1549053188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMC\" target=\"_blank\">FMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428807-fmc-corpplus-7-after-big-q4-guidance-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FMC Corp. +7% after big Q4 guidance raise</a></h4><ul><li>FMC Corp. (<a href='https://seekingalpha.com/symbol/FMC' title='FMC Corporation'>FMC</a> <font color='green'>+7%</font>) surges after <a href=\"https://seekingalpha.com/pr/17398577-fmc-corporation-raises-guidance-fourth-quarter-2018-earnings-provides-initial-2019-outlook\" target=\"_blank\">raising Q4 EPS guidance</a> to $1.62-$1.67, up 17%-21% vs. the midpoint of prior guidance of $1.33-$1.43.</li><li>FMC says the improved guidance is primarily due to outperformance in its Agricultural Solutions segment, where revenue rose 18% Y/Y on a pro forma basis vs. prior guidance of 12% growth, enjoying strong demand across all regions.</li><li>For FY 2019, FMC expects revenue growth of 4%-6% vs. pro forma 2018 revenue and total company EBITDA growth of 5%-9% vs. pro forma 2018, despite significant headwinds from raw  material costs and foreign exchange, with EPS of $5.55-$5.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428807\" data-linked=\"FMC Corp. +7% after big Q4 guidance raise\" data-tweet=\"$FMC - FMC Corp. +7% after big Q4 guidance raise https://seekingalpha.com/news/3428807-fmc-corpplus-7-after-big-q4-guidance-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3428807-fmc-corpplus-7-after-big-q4-guidance-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428802\" data-ts=\"1549051561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LINK\" target=\"_blank\">LINK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428802-technology-movers-and-shakers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology movers and shakers</a></h4><ul><li><strong>Gainers: </strong>Interlink Electronics (NASDAQ:<a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics'>LINK</a>) <font color=\"green\">+53%</font>. Gravity (NASDAQ:<a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a>) <font color=\"green\">+30%</font>. Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a>) <font color=\"green\">+24%</font>. SITO Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a>) <font color=\"green\">+15%</font>. Infinera Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers: </strong>Celestica (NYSE:<a href='https://seekingalpha.com/symbol/CLS' title='Celestica Inc.'>CLS</a>) <font color=\"red\">-19%</font>. Bottomline Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/EPAY' title='Bottomline Technologies, Inc.'>EPAY</a>) <font color=\"red\">-17%</font>. Daqo New Energy (NYSE:<a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a>) <font color=\"red\">-14%</font>. Attunity (NASDAQ:<a href='https://seekingalpha.com/symbol/ATTU' title='Attunity Ltd'>ATTU</a>) <font color=\"red\">-13%</font>. Canadian Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428802\" data-linked=\"Technology movers and shakers\" data-tweet=\"$LINK $LINK $GRVY - Technology movers and shakers https://seekingalpha.com/news/3428802-technology-movers-and-shakers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428802-technology-movers-and-shakers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428795\" data-ts=\"1549049960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISBC\" target=\"_blank\">ISBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428795-investors-bancorp-gets-couple-of-post-earnings-upgrades-shares-gain-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors Bancorp gets a couple of post-earnings upgrades; shares gain 4%</a></h4><ul><li>Shares rose yesterday following a Q4 earnings beat, and they're on the move again today as Piper's Matthew Breese and Wells Fargo's Jared Shaw both upgrade to the equivalent of Buy.</li><li>Breese expects pressure on net interest margin to subside and sees 22M shares being bought back this year vs. 20M in 2018.</li><li>There's also the chance of a sale, but the stock's recent run higher means maybe not as much upside. Breese sets a $13.50 price target.</li><li>Shaw lifts his price target to $15.</li><li><a href='https://seekingalpha.com/symbol/ISBC' title='Investors Bancorp, Inc.'>ISBC</a> <font color=\"green\">+4%</font> to $12.63.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428795\" data-linked=\"Investors Bancorp gets a couple of post-earnings upgrades; shares gain 4%\" data-tweet=\"$ISBC - Investors Bancorp gets a couple of post-earnings upgrades; shares gain 4% https://seekingalpha.com/news/3428795-investors-bancorp-gets-couple-of-post-earnings-upgrades-shares-gain-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3428795-investors-bancorp-gets-couple-of-post-earnings-upgrades-shares-gain-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428794\" data-ts=\"1549049496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNI\" target=\"_blank\">MNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428794-report-mcclatchy-offers-voluntary-buyout-to-10-of-force\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: McClatchy offers voluntary buyout to 10% of force</a></h4><ul>   <li>McClatchy (<a href=\"http://seekingalpha.com/symbol/MNI\" target=\"_blank\">MNI</a> <font color=\"green\">+4.4%</font>) has offered 10% of its employees <a href=\"https://www.miaminewtimes.com/news/mcclatchy-follows-buzzfeed-vice-and-others-in-cutting-staff-11070151\" target=\"_blank\">voluntary buyouts</a>, according to the <i>Miami New Times.</i></li>    <li>It cites an employee mail from CEO Craig Forman that refers to the buyout as a \"one-time opportunity.\"</li>    <li>The company called a 2 p.m. meeting at the Miami Herald, its most significant newspaper, to provide details.</li>    <li>Other papers in the chain include <i>The Kansas City Star, </i>the<i> Idaho Statesman, The Fresno Bee</i> and <i>The Charlotte Observer.</i></li> </ul><div class=\"tiny-share-widget\" data-id=\"3428794\" data-linked=\"Report: McClatchy offers voluntary buyout to 10% of force\" data-tweet=\"$MNI - Report: McClatchy offers voluntary buyout to 10% of force https://seekingalpha.com/news/3428794-report-mcclatchy-offers-voluntary-buyout-to-10-of-force?source=tweet\" data-url=\"https://seekingalpha.com/news/3428794-report-mcclatchy-offers-voluntary-buyout-to-10-of-force\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428792\" data-ts=\"1549049276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPR\" target=\"_blank\">SPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428792-spirit-aeroplus-5-foreseeing-strong-2019-on-rising-demand-from-boeing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit Aero +5%, foreseeing strong 2019 on rising demand from Boeing</a></h4><ul><li>Spirit AeroSystems (<a href='https://seekingalpha.com/symbol/SPR' title='Spirit AeroSystems Holdings, Inc.'>SPR</a> <font color='green'>+5.4%</font>) soars higher after beating <a href=\"https://seekingalpha.com/news/3428561-spirit-aerosystems-beats-0_07-misses-revenue\" target=\"_blank\">Q4 earnings</a> expectations and guiding FY 2019 earnings and revenue above Wall Street estimates, as it prepares to meet higher demand for fuselages and other aircraft parts from top customer Boeing.</li><li>SPR sees FY 2019 revenues rising ~14% Y/Y to $8B-$8.2B, above $7.64B analyst consensus, <a href=\"https://www.reuters.com/article/us-spirit-aerosystm-results/spirit-aero-expects-strong-2019-on-higher-demand-from-boeing-idUSKCN1PQ4QK\" target=\"_blank\">largely driven by Boeing's 737</a>, and EPS of $7.35-$7.60 vs. $7.34 consensus; the company makes ~70% of Boeing\u2019s best-selling commercial jetliner 737\u2019s structure.</li><li>SPR expects to increase the production of the jet parts to 57 units per month this year from 52 last year, CEO Tom Gentile said during today's earnings conference call.</li><li>SPR also expects operating margins of 16.5% in 2019, up from 15% last year, as it prepares to raise production on aircraft programs, including 14 units per month on Boeing\u2019s 787 Dreamliner and 60 per month on the Airbus A320.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428792\" data-linked=\"Spirit Aero +5%, foreseeing strong 2019 on rising demand from Boeing\" data-tweet=\"$SPR - Spirit Aero +5%, foreseeing strong 2019 on rising demand from Boeing https://seekingalpha.com/news/3428792-spirit-aeroplus-5-foreseeing-strong-2019-on-rising-demand-from-boeing?source=tweet\" data-url=\"https://seekingalpha.com/news/3428792-spirit-aeroplus-5-foreseeing-strong-2019-on-rising-demand-from-boeing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428784\" data-ts=\"1549047520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPN\" target=\"_blank\">SPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428784-superior-energy-services-and-smart-sand-among-energy-materials-gainers-magnegas-applied\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Superior Energy Services and Smart Sand among Energy/Materials gainers; MagneGas Applied Technology Solutions and Vedanta among losers</a></h4><ul><li><b>Gainers: </b>Superior Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a>) <font color=\"green\">+13%</font>. Smart Sand (NASDAQ:<a href='https://seekingalpha.com/symbol/SND' title='Smart Sand'>SND</a>) <font color=\"green\">+13%</font>. Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"green\">+13%</font>. Pioneer Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a>) <font color=\"green\">+12%</font>. Legacy Reserves (NASDAQ:<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>MagneGas Applied Technology Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a>) <font color=\"red\">-30%</font>. Vedanta (NYSE:<a href='https://seekingalpha.com/symbol/VEDL' title='Vedanta Ltd'>VEDL</a>) <font color=\"red\">-17%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"red\">-6%</font>. CNX Resources (NYSE:<a href='https://seekingalpha.com/symbol/CNX' title='CNX Resources Corporation'>CNX</a>) <font color=\"red\">6%</font>. Blueknight Energy Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/BKEP' title='Blueknight Energy Partners'>BKEP</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428784\" data-linked=\"Superior Energy Services and Smart Sand among Energy/Materials gainers; MagneGas Applied Technology Solutions and Vedanta among losers\" data-tweet=\"$SPN $SPN $SND - Superior Energy Services and Smart Sand among Energy/Materials gainers; MagneGas Applied Technology Solutions and Vedanta among losers https://seekingalpha.com/news/3428784-superior-energy-services-and-smart-sand-among-energy-materials-gainers-magnegas-applied?source=tweet\" data-url=\"https://seekingalpha.com/news/3428784-superior-energy-services-and-smart-sand-among-energy-materials-gainers-magnegas-applied\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428782\" data-ts=\"1549047339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FUJHF\" target=\"_blank\">FUJHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428782-subaru-u-s-salesplus-3_9-in-january\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Subaru U.S. sales +3.9% in January</a></h4><ul> <li>Subaru (<a href='https://seekingalpha.com/symbol/FUJHF' title='Subaru Corporation'>OTCPK:FUJHF</a>) unit sales <a href=\"https://seekingalpha.com/pr/17399396-subaru-america-inc-reports-best-ever-january-sales\" sasource=\"qp_sum_news_4\" target=\"_blank\">+3.9%</a> to 46,072 units in January.</li><li>Sales by model: Forester +22.8% to 13,318 unit; Outback -17.6% to 10,941; Crosstek -12.7% to 8,236.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428782\" data-linked=\"Subaru U.S. sales +3.9% in January\" data-tweet=\"$FUJHF $FUJHY - Subaru U.S. sales +3.9% in January https://seekingalpha.com/news/3428782-subaru-u-s-salesplus-3_9-in-january?source=tweet\" data-url=\"https://seekingalpha.com/news/3428782-subaru-u-s-salesplus-3_9-in-january\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428778\" data-ts=\"1549047027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIMTF\" target=\"_blank\">KIMTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428778-kia-motors-america-announces-january-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kia Motors America announces January sales</a></h4><ul><li>Kia Motors America (<a href='https://seekingalpha.com/symbol/KIMTF' title='Kia Motors Corp.'>OTCPK:KIMTF</a>) units sales rose <a href=\"https://seekingalpha.com/pr/17399385-kia-motors-america-announces-january-sales\" sasource=\"qp_sum_news_1\" target=\"_blank\">4.9%</a> to 37,376 in January.</li><li>The sales were led by 19.6% growth in Soul model, +12.6% in Optima model, 4.4% gain in Sportage CUV and Sorento +9.8%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428778\" data-linked=\"Kia Motors America announces January sales\" data-tweet=\"$KIMTF - Kia Motors America announces January sales https://seekingalpha.com/news/3428778-kia-motors-america-announces-january-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3428778-kia-motors-america-announces-january-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428774\" data-ts=\"1549046238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMC\" target=\"_blank\">HMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428774-american-honda-reports-sales-growth-of-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Honda reports sales growth of 1.5%</a></h4><ul><li>Honda (<a href='https://seekingalpha.com/symbol/HMC' title='Honda Motor Co., Ltd.'>HMC</a> <font color='red'>-3%</font>) unit sales <a href=\"https://seekingalpha.com/pr/17399250-american-honda-reports-sales-increases-honda-acura-brands-despite-winter-chill\" sasource=\"qp_sum_news_6\" target=\"_blank\">+1.5%</a> to 106,139 units vs. +6.3% forecast by Edmunds.</li><li>Car sales dropped 1.7% and truck sales rose 4.3%.</li><li>Sales in the Honda division grew 0.8% to 96,375 units, while Acura sales up 9.6% to 9,764 units, led by 20.4% rise in trucks</li><li>Civic sales fell 9.2% while Accord sales advanced 6.3% for the month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428774\" data-linked=\"American Honda reports sales growth of 1.5%\" data-tweet=\"$HMC $HNDAF - American Honda reports sales growth of 1.5% https://seekingalpha.com/news/3428774-american-honda-reports-sales-growth-of-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3428774-american-honda-reports-sales-growth-of-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428772\" data-ts=\"1549045620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSANF\" target=\"_blank\">NSANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428772-nissan-group-u-s-sales-dropped-18_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nissan Group U.S. sales dropped 18.5%</a></h4><ul><li>Nissan (<a href='https://seekingalpha.com/symbol/NSANY' title='Nissan Motor Co., Ltd. ADR'>OTCPK:NSANY</a>) unit sales <a href=\"https://seekingalpha.com/pr/17399313-nissan-group-reports-january-2019-u-s-sales\" sasource=\"qp_sum_news_21\" target=\"_blank\">-18.5%</a> to 100,741 units vs. -15.2% forecast by Edmunds.</li><li>Nissan truck sales contracted  13.2% Y/Y to 60,556 units.</li><li>Nissan car sales declined 25.3% to 40,185 units.</li><li>Sales growth by brand: Nissan -19.9% to 90,439 units; Infiniti -3.1% to 10,302 units.</li><li>Rogue sales fell 27.8% to 26,113 units during the month.</li><li>Sentra down 20.5% to 14,088 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428772\" data-linked=\"Nissan Group U.S. sales dropped 18.5%\" data-tweet=\"$NSANF $NSANY - Nissan Group U.S. sales dropped 18.5% https://seekingalpha.com/news/3428772-nissan-group-u-s-sales-dropped-18_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3428772-nissan-group-u-s-sales-dropped-18_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428766\" data-ts=\"1549045010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POAHY\" target=\"_blank\">POAHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428766-porsche-u-s-retail-sales-rose-12_5-in-january\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Porsche U.S. retail sales rose 12.5% in January</a></h4><ul><li>Porsche (<a href='https://seekingalpha.com/symbol/POAHY' title='Porsche Automobile Holding SE ADR'>OTCPK:POAHY</a>) unit sales rose <a href=\"https://seekingalpha.com/pr/17399348-porsche-starts-2019-record-u-s-retail-sales-january\" sasource=\"qp_sum_news_3\" target=\"_blank\">12.5%</a> to 5,419 units in January.</li><li>911 sales up 29.1% to 1,101 units.</li><li>718 sales down 36.6% to 263 units</li><li>Cayenne sales expanded 65.1% to 2,150 units.</li><li>Panamera sales decreased 20.2% to 487 units.</li><li>Macan sales dropped 13.3% to 1,418 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428766\" data-linked=\"Porsche U.S. retail sales rose 12.5% in January\" data-tweet=\"$POAHY $POAHF - Porsche U.S. retail sales rose 12.5% in January https://seekingalpha.com/news/3428766-porsche-u-s-retail-sales-rose-12_5-in-january?source=tweet\" data-url=\"https://seekingalpha.com/news/3428766-porsche-u-s-retail-sales-rose-12_5-in-january\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428764\" data-ts=\"1549044634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HYMLF\" target=\"_blank\">HYMLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428764-hyundai-motor-january-u-s-sales-rose-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hyundai Motor January U.S. sales rose 3%</a></h4><ul><li>Hyundai (<a href='https://seekingalpha.com/symbol/HYMLF' title='Hyundai Motor Co., Ltd.'>OTCPK:HYMLF</a>) reports U.S. sales rose <a href=\"https://seekingalpha.com/pr/17399356-hyundai-motor-america-reports-january-2019-sales\" sasource=\"qp_sum_news_2\" target=\"_blank\">3%</a> in January to 40,796 units.</li><li>Hyundai sold 21,007 SUVs, representing 51% of the total sales volume.</li><li>Volume leaders during the month were the Elantra (9,942 units), Santa Fe (7,832 units) and Tucson (7,444 units).</li><li>\"We are pleased with Hyundai's start to 2019 as we hit our January objectives, following a record-breaking December and several challenges outside of our control,\" said John Cook, director, Sales Operations, Hyundai Motor America. \"We've also started the year with many positives as Hyundai won several prestigious industry recognitions, including Utility Vehicle of the Year and Car and Driver 10Best for Kona and Kona EV.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3428764\" data-linked=\"Hyundai Motor January U.S. sales rose 3%\" data-tweet=\"$HYMLF $HYMTF $HYMPF - Hyundai Motor January U.S. sales rose 3% https://seekingalpha.com/news/3428764-hyundai-motor-january-u-s-sales-rose-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3428764-hyundai-motor-january-u-s-sales-rose-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428763\" data-ts=\"1549044523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYMC\" target=\"_blank\">SYMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428763-wedbush-raises-symantec-on-stellar-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wedbush raises Symantec on &quot;stellar&quot; quarter</a></h4><ul><li>Wedbush analyst Dan Ives says Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) \"is starting to get its mojo back\" after execution struggles citing the \"stellar\" <a href=\"https://seekingalpha.com/news/3428403-symantec-plus-5-percent-q3-beats-upside-fy-guide\" target=\"_blank\">earnings report</a>.</li><li>Ives calls enterprise security the \"star of the show\" and notes that Symantec finally sees \"the fruits of the Blue Coat acquisition.\"</li><li>Ives maintains a Neutral rating on SYMC but raises the target from $21 to $24.</li><li>Symantec shares are <font color=\"green\">up 9.4%</font> to $22.99.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428763\" data-linked=\"Wedbush raises Symantec on &quot;stellar&quot; quarter\" data-tweet=\"$SYMC $NLOK - Wedbush raises Symantec on &quot;stellar&quot; quarter https://seekingalpha.com/news/3428763-wedbush-raises-symantec-on-stellar-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3428763-wedbush-raises-symantec-on-stellar-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428760\" data-ts=\"1549044351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVS\" target=\"_blank\">CVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428760-drug-wholesalers-pbms-claw-back-from-selloff-from-proposed-elimination-of-rebates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Drug wholesalers/PBMs claw back from selloff from proposed elimination of rebates</a></h4><ul><li>Drug wholesalers and pharmacy benefit managers (PBMs) are under modest pressure on the heels of a <a href=\"https://www.modernhealthcare.com/article/20190131/NEWS/190139972\" target=\"_blank\">proposed rule</a> from the U.S. Department of Health and Human Services &#40;HHS&#41; that would significantly alter the drug rebate landscape.</li><li>HHS wants to remove the discounts drug makers pay to PBMs, Medicare and managed care plans from safe harbor protection under anti-kickback laws, but allow price reductions given to patients at the pharmacy counter.</li><li>Another proposed safe harbor would allow PBMs to earn a flat service fee from manufacturers for services rendered, such as medical education or data monitoring/management.</li><li>PBMs currently earn a percentage of the list price of drugs which keeps driving prices up.</li><li>HHS also wants more transparency on PBM deals with drugmakers.</li><li>The 60-day comment period is underway. If finalized, the industry will have 60 day to implement.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a> <font color=\"red\">-0.1%</font>)(<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"red\">-0.2%</font>)(<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a> <font color=\"red\">-0.6%</font>)(<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a> <font color=\"red\">-0.1%</font>)(<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health Inc.'>CAH</a> <font color=\"red\">-0.8%</font>)(<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a> <font color=\"red\">-0.1%</font>)(<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a> <font color=\"red\">-0.5%</font>)(<a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a>)(<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color=\"red\">-0.7%</font>)(<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color=\"green\">+3%</font>)(<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"green\">+0.7%</font>)(<a href='https://seekingalpha.com/symbol/TAK' title='Takeda Pharmaceutical Co., Ltd. ADR'>TAK</a> <font color='green'>+2.1%</font>)(<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color='green'>+0.7%</font>)(<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color='red'>-0.2%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='green'>+0.1%</font>)(<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a> <font color='red'>-0.2%</font>)(<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='green'>+0.6%</font>)(<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='green'>+2.6%</font>)(<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='green'>+3.8%</font>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='green'>+0.4%</font>)(<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428760\" data-linked=\"Drug wholesalers/PBMs claw back from selloff from proposed elimination of rebates\" data-tweet=\"$CVS $CVS $ANTM - Drug wholesalers/PBMs claw back from selloff from proposed elimination of rebates https://seekingalpha.com/news/3428760-drug-wholesalers-pbms-claw-back-from-selloff-from-proposed-elimination-of-rebates?source=tweet\" data-url=\"https://seekingalpha.com/news/3428760-drug-wholesalers-pbms-claw-back-from-selloff-from-proposed-elimination-of-rebates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>90&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428755\" data-ts=\"1549044094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYL\" target=\"_blank\">LYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428755-dragon-victory-international-leads-financial-gainers-yangtze-river-port-and-logistics-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dragon Victory International leads financial gainers; Yangtze River Port and Logistics among losers</a></h4><ul><li><b>Gainers: </b>Dragon Victory International (NASDAQ:<a href='https://seekingalpha.com/symbol/LYL' title='Dragon Victory International Limited'>LYL</a>) <font color=\"green\">+11%</font>. Enova International (NYSE:<a href='https://seekingalpha.com/symbol/ENVA' title='Enova International, Inc.'>ENVA</a>) <font color=\"green\">+10%</font>. LPL Financial Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LPLA' title='LPL Financial Holdings Inc.'>LPLA</a>) <font color=\"green\">+8%</font>. North European Oil Royalty Trust (NYSE:<a href='https://seekingalpha.com/symbol/NRT' title='North European Oil Royalty Trust'>NRT</a>) <font color=\"green\">+8%</font>. Stifel Financial (NYSE:<a href='https://seekingalpha.com/symbol/SF' title='Stifel Financial Corporation'>SF</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>WisdomTree Investments (NASDAQ:<a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a>) <font color=\"red\">-9%</font>. Yangtze River Port and Logistics (NASDAQ:<a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a>) <font color=\"red\">-7%</font>. CURO Group Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CURO' title='CURO Group Holdings Corp.'>CURO</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428755\" data-linked=\"Dragon Victory International leads financial gainers; Yangtze River Port and Logistics among losers\" data-tweet=\"$LYL $LYL $ENVA - Dragon Victory International leads financial gainers; Yangtze River Port and Logistics among losers https://seekingalpha.com/news/3428755-dragon-victory-international-leads-financial-gainers-yangtze-river-port-and-logistics-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3428755-dragon-victory-international-leads-financial-gainers-yangtze-river-port-and-logistics-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428752\" data-ts=\"1549043549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMSR\" target=\"_blank\">TMSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428752-microcaps-dominate-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate midday movers</a></h4><ul><li><strong>Gainers:</strong> TMSR Holding Company (NASDAQ:<a href='https://seekingalpha.com/symbol/TMSR' title='TMSR Holding Co., Ltd.'>TMSR</a>) <font color=\"green\">+223%. </font>Integrated Media Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/IMTE' title='Integrated Media Technology Limited'>IMTE</a>) <font color=\"green\">+104%</font>. Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) <font color=\"green\">+34%. </font>Professional Diversity Network (NASDAQ:<a href='https://seekingalpha.com/symbol/IPDN' title='Professional Diversity Network'>IPDN</a>) <font color=\"green\">+30%</font>. Continental Materials (NYSEMKT:<a href='https://seekingalpha.com/symbol/CUO' title='Continental Materials Corp'>CUO</a>) <font color=\"green\">+29%</font>. Gravity (NASDAQ:<a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a>) <font color=\"green\">+28%</font>. Interlink Electronics (NASDAQ:<a href='https://seekingalpha.com/symbol/LINK' title='Interlink Electronics'>LINK</a>) <font color=\"green\">+20%</font>. Tuesday Morning (NASDAQ:<a href='https://seekingalpha.com/symbol/TUES' title='Tuesday Morning Corp.'>TUES</a>) <font color=\"green\">+18%</font>. Aileron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALRN' title='Aileron Therapeutics'>ALRN</a>) <font color=\"green\">+21%</font>. Enochian Biosciences (<a href='https://seekingalpha.com/symbol/ENOB' title='Enochian Biosciences Inc.'>OTCQB:ENOB</a>) <font color=\"green\">+17%</font>.</li> <li><strong>Losers: </strong>Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a>) <font color=\"red\">-23%</font>. MagneGas Applied Technology Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a>) <font color=\"red\">-22%</font>. Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a>) <font color=\"red\">-19%</font>. Bottomline Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/EPAY' title='Bottomline Technologies, Inc.'>EPAY</a>) <font color=\"red\">-18%</font>. Vedanta Limited (NYSE:<a href='https://seekingalpha.com/symbol/VEDL' title='Vedanta Ltd'>VEDL</a>) <font color=\"red\">-17%</font>. Cleveland BioLabs (NASDAQ:<a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a>) <font color=\"red\">-17%</font>. Celestica (NYSE:<a href='https://seekingalpha.com/symbol/CLS' title='Celestica Inc.'>CLS</a>) <font color=\"red\">-17%</font>. Matthews International (NASDAQ:<a href='https://seekingalpha.com/symbol/MATW' title='Matthews International Corporation'>MATW</a>) <font color=\"red\">-15%</font>. Nuvectra Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a>) <font color=\"red\">-14%</font>. NovaBay Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/NBY' title='NovaBay Pharmaceuticals, Inc.'>NBY</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428752\" data-linked=\"Microcaps dominate midday movers\" data-tweet=\"$TMSR $TMSR $IMTE - Microcaps dominate midday movers https://seekingalpha.com/news/3428752-microcaps-dominate-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428752-microcaps-dominate-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428751\" data-ts=\"1549043307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMP\" target=\"_blank\">MMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428751-magellan-midstreamminus-6-in-two-days-since-disappointing-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Magellan Midstream -6% in two days since disappointing Q4 results</a></h4><ul><li>Magellan Midstream Partners (<a href='https://seekingalpha.com/symbol/MMP' title='Magellan Midstream Partners, L.P.'>MMP</a> <font color=\"red\">-2.1%</font>) tumbles for a second straight day after reporting <a href=\"https://seekingalpha.com/news/3428150-magellan-midstream-slips-guiding-q1-fy-2019-eps-consensus\" target=\"_blank\">disappointing Q4 earnings</a>, below consensus earnings guidance and a decline in distributable cash flow; shares have dropped nearly 6% in two days.</li><li>MMP said it <a href=\"https://www.reuters.com/article/us-magellan-mids-crude-pipeline/magellan-cancels-plan-for-short-haul-oil-pipeline-in-west-texas-idUSKCN1PP2ZP\" target=\"_blank\">canceled plans</a> to develop a stand-alone crude pipeline in west Texas, as it considers a lower-cost project for the same region to meet shipper needs in an effort to be more capital efficient.</li><li>\u201cIt would be a much, much lower capital investment, and it would be a much more efficient way for us to source barrels into Longhorn [pipeline] for our customers,\u201d CEO Michael Mears said in the company's <a href=\"https://seekingalpha.com/article/4237305-magellan-midstream-partners-lp-mmp-ceo-mike-mears-q4-2018-results-earnings-call-transcript\" target=\"_blank\">earnings conference call</a>.</li><li>MMP had estimated that the pipeline would cost $150M, and said in the call that a writeoff related to the project reduced Q4 distributable cash flow by $9M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428751\" data-linked=\"Magellan Midstream -6% in two days since disappointing Q4 results\" data-tweet=\"$MMP - Magellan Midstream -6% in two days since disappointing Q4 results https://seekingalpha.com/news/3428751-magellan-midstreamminus-6-in-two-days-since-disappointing-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428751-magellan-midstreamminus-6-in-two-days-since-disappointing-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428750\" data-ts=\"1549043180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVO\" target=\"_blank\">NVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428750-novo-stockpiling-product-in-uk-ahead-of-brexit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novo stockpiling product in UK ahead of Brexit</a></h4><ul><li>The WSJ reports that Novo Nordisk (<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color=\"green\">+4.3%</font>) will be using more capital than normal as its <a href=\"https://www.wsj.com/articles/danish-drugmaker-expects-higher-working-capital-needs-ahead-of-brexit-11549041507?mod=searchresults&amp;page=1&amp;pos=1\" target=\"_blank\">builds inventories</a> in the UK ahead of the Britain's March 29 exit from the EU (Brexit).</li><li>CFO Karsten Munk says the company has more than doubled its stockpile of medications so its working capital/sales ratio, 4.4% last year, will increase despite the UK's modest 2 - 3% slice of global sales.</li><li>Other medical firms are doing the same and have been for some time.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428750\" data-linked=\"Novo stockpiling product in UK ahead of Brexit\" data-tweet=\"$NVO - Novo stockpiling product in UK ahead of Brexit https://seekingalpha.com/news/3428750-novo-stockpiling-product-in-uk-ahead-of-brexit?source=tweet\" data-url=\"https://seekingalpha.com/news/3428750-novo-stockpiling-product-in-uk-ahead-of-brexit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428747\" data-ts=\"1549042007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428747-exxonplus-4-on-strong-q4-blow-out-downstream-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon +4% on strong Q4, &#39;blow-out&#39; downstream results</a></h4><ul><li>Exxon Mobil (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='green'>+3.6%</font>) surges in the wake of <a href=\"https://seekingalpha.com/news/3428625-exxon-plus-2-percent-q4-earnings-top-estimates-big-refining-boost\" target=\"_blank\">strong Q4 earnings</a> as refining profits more than doubled to $2.7B and oil and gas production topped 4M bbl/day for the first time since early 2017.</li><li>XOM enjoyed \"<a href=\"https://finance.yahoo.com/news/exxon-bounces-back-crude-oil-130446928.html\" target=\"_blank\">blow-out downstream results</a>,\" says Jefferies analyst Jason Gammel, and oil and gas production results were \"especially strong,\" says Brian Youngberg at Edward Jones.</li><li>Production declines have been a significant issue for XOM, and Raymond James analyst Muhammed Ghulam says the Q4 improvement is a \"positive sign\" but the earnings beat was \"partially driven by one-time asset sale gains of more than $800M\" from a refinery sale.</li><li>The company says it expects $30B in capital spending this year, up from a previous forecast of $28B, which J.P. Morgan says \"takes away from the sizzle of the quarter.\"</li><li>In XOM's earnings conference call, CEO Darren Woods credited the better than expected Q4 to the company <a href=\"https://www.reuters.com/article/us-exxon-mobil-results/exxon-mobil-profit-tops-estimates-as-production-rebounds-idUSKCN1PQ4SV\" target=\"_blank\">optimizing its operations</a> across the board, and said it has an advantage because of its ability to tie decisions in the oil field to logistics and refining.</li><li>Also in the call, XOM said it would not use asset sales to fund a ramp-up in projects, each of the five growth area growth opportunities outlined in March saw significant progress over the year, and the company plans to sanction two Baytown projects this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428747\" data-linked=\"Exxon +4% on strong Q4, &#39;blow-out&#39; downstream results\" data-tweet=\"$XOM - Exxon +4% on strong Q4, &#39;blow-out&#39; downstream results https://seekingalpha.com/news/3428747-exxonplus-4-on-strong-q4-blow-out-downstream-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428747-exxonplus-4-on-strong-q4-blow-out-downstream-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428741\" data-ts=\"1549040685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCLR\" target=\"_blank\">OCLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428741-infinera-pops-to-highest-point-since-q3-shortfall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera pops to highest point since Q3 shortfall</a></h4><ul>   <li>Infinera's (<a href=\"http://seekingalpha.com/symbol/INFN\" target=\"_blank\">INFN</a> <font color=\"green\">+12.7%</font>) up by double digits today on no particular news, but heavy volume that's already surpassed its daily average.</li>    <li>They've touched their highest point since Nov. 6, when its last earnings report showed a <a href=\"https://seekingalpha.com/news/3406267-infinera-slides-25-percent-revenues-still-come-short\" target=\"_blank\">\"spending pause\" that caused revenues to miss</a> in its third quarter.</li>    <li>Its latest SEC filing before today's open showed Greg Dougherty -- the former CEO of Oclaro (NASDAQ:<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a>) before that company's acquisition by Lumentum -- acquiring <a href=\"https://seekingalpha.com/filing/4322100\" target=\"_blank\">37,844 restricted stock units</a>.</li>    <li>On Tuesday, the company appointed Dougherty to its board.</li>    <li>It's expected to report Q4 earnings after the close on Feb. 21, with the Street forecasting EPS of -$0.27 on revenues of $324.9M.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3428741\" data-linked=\"Infinera pops to highest point since Q3 shortfall\" data-tweet=\"$OCLR $OCLR $INFN - Infinera pops to highest point since Q3 shortfall https://seekingalpha.com/news/3428741-infinera-pops-to-highest-point-since-q3-shortfall?source=tweet\" data-url=\"https://seekingalpha.com/news/3428741-infinera-pops-to-highest-point-since-q3-shortfall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428738\" data-ts=\"1549040529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DECK\" target=\"_blank\">DECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428738-deckers-outdoor-leads-consumer-gainers-sony-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deckers Outdoor leads consumer gainers; Sony among losers</a></h4><ul><li><b>Gainers: </b>Deckers Outdoor (NASDAQ:<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a>) <font color=\"green\">+14%</font>. Post Holdings (NYSE:<a href='https://seekingalpha.com/symbol/POST' title='Post Holdings, Inc.'>POST</a>) <font color=\"green\">+7%</font>. Youngevity International (NASDAQ:<a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Farmmi (NASDAQ:<a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a>) <font color=\"red\">-14%</font>. Sony (NYSE:<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a>) <font color=\"red\">-9%</font>. Mobile Mini (NASDAQ:<a href='https://seekingalpha.com/symbol/MINI' title='Mobile Mini, Inc.'>MINI</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428738\" data-linked=\"Deckers Outdoor leads consumer gainers; Sony among losers\" data-tweet=\"$DECK $DECK $POST - Deckers Outdoor leads consumer gainers; Sony among losers https://seekingalpha.com/news/3428738-deckers-outdoor-leads-consumer-gainers-sony-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428738-deckers-outdoor-leads-consumer-gainers-sony-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428737\" data-ts=\"1549040434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHA\" target=\"_blank\">APHA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428737-citron-rings-register-on-aphria\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron rings the register on Aphria</a></h4><ul><li>With shares <font color=\"green\">up 60%</font> since he got bullish one month ago, Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) - among other pot names that are moving into the U.S. - has run too far, <a href=\"https://twitter.com/CitronResearch/status/1091361466945482752\" target=\"_blank\">tweets Andrew Left</a>. He's taking profits.</li><li>Cronos (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) - trading 70% above analyst targets - is a short, he adds.</li><li>Aphria and Cronos, continue to be bid higher, with both <font color=\"green\">up just shy of 10%</font> today.</li><li>The ETFMG Alternative Harvest ETF (<a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a> <font color='green'>+2.9%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3428737\" data-linked=\"Citron rings the register on Aphria\" data-tweet=\"$APHA $APHA $CRON - Citron rings the register on Aphria https://seekingalpha.com/news/3428737-citron-rings-register-on-aphria?source=tweet\" data-url=\"https://seekingalpha.com/news/3428737-citron-rings-register-on-aphria\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428734\" data-ts=\"1549040149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHM\" target=\"_blank\">ATHM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428734-januarys-tech-winners-and-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">January&#39;s tech winners and losers</a></h4><ul><li>The tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) is <font color=\"green\">up 1%</font> and the Philadelphia Semiconductor Index <font color=\"green\">gains 1.6%</font> as we close out a week of big tech earnings (including Amazon, Apple, and Microsoft) with President Trump optimistic on a China trade deal.</li><li>The US-China trade ware made January a rough month for China-exposed tech stocks. Chinese internet stocks were among the largest decliners in the month with Autohome (NYSE:<a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a>) <font color=\"red\">down 7.5%</font>, Bitauto (NYSE:<a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a>) <font color=\"red\">down 22%</font>, and Uxin (NASDAQ:<a href='https://seekingalpha.com/symbol/UXIN' title='Uxin'>UXIN</a>) <font color=\"red\">down 29.8%</font>.</li><li>Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) <font color=\"red\">fell 23%</font> to become one of the largest U.S. large-cap decliners in the past month. Legal challenges with Apple and the FTC weighed QCOM before this week's earnings report beat estimates.</li><li>January gainers included Luxoft (NYSE:<a href='https://seekingalpha.com/symbol/LXFT' title='Luxoft Holding Inc'>LXFT</a>) <font color=\"green\">+90.8%</font> after DXC acquired the company for $2B, Xerox (NYSE:<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Corporation'>XRX</a>) <font color=\"green\">+42.8%</font> on mixed earnings and Citi mentioning its buyout potential, and AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) <font color=\"green\">+32%</font> benefitting from Nvidia's earnings warning.</li><li>Related broad tech ETFs: <a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>, <a href='https://seekingalpha.com/symbol/VGT' title='Vanguard Information Technology ETF'>VGT</a>, <a href='https://seekingalpha.com/symbol/TECL' title='Direxion Technology Bull 3x Shares ETF'>TECL</a>, <a href='https://seekingalpha.com/symbol/FTEC' title='Fidelity MSCI Information Technology Index ETF'>FTEC</a>, <a href='https://seekingalpha.com/symbol/IYW' title='iShares U.S. Technology ETF'>IYW</a>, <a href='https://seekingalpha.com/symbol/ROM' title='ProShares Ultra Technology ETF'>ROM</a>, <a href='https://seekingalpha.com/symbol/QTEC' title='First Trust NASDAQ-100-Tech Index ETF'>QTEC</a>, <a href='https://seekingalpha.com/symbol/RYT' title='Invesco S&P 500 Equal Weight Technology ETF'>RYT</a>, <a href='https://seekingalpha.com/symbol/FNG' title='AdvisorShares New Tech and Media ETF'>FNG</a>, <a href='https://seekingalpha.com/symbol/TECS' title='Direxion Technology Bear 3x Shares ETF'>TECS</a>, <a href='https://seekingalpha.com/symbol/IGM' title='iShares North American Tech ETF'>IGM</a>, <a href='https://seekingalpha.com/symbol/FXL' title='First Trust Tech AlphaDEX ETF'>FXL</a>, <a href='https://seekingalpha.com/symbol/XNTK' title='SPDR NYSE Technology ETF'>XNTK</a>, <a href='https://seekingalpha.com/symbol/REW' title='ProShares UltraShort Technology ETF'>REW</a>, <a href='https://seekingalpha.com/symbol/JHMT' title='John Hancock Multifactor Technology ETF'>JHMT</a>, <a href='https://seekingalpha.com/symbol/XITK' title='SPDR Innovative Technology ETF'>XITK</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428734\" data-linked=\"January&#39;s tech winners and losers\" data-tweet=\"$ATHM $XLK $ATHM - January&#39;s tech winners and losers https://seekingalpha.com/news/3428734-januarys-tech-winners-and-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428734-januarys-tech-winners-and-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428726\" data-ts=\"1549039184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFT\" target=\"_blank\">WFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428726-weatherfordplus-22-investors-ignore-q4-miss-focus-on-free-cash-flow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weatherford +22% as investors ignore Q4 miss, focus on free cash flow</a></h4><ul><li>Waetherford (<a href='https://seekingalpha.com/symbol/WFT' title='Weatherford International Ltd.'>WFT</a> <font color='green'>+21.7%</font>) turns from red to bright green despite its <a href=\"https://seekingalpha.com/news/3428532-weatherford-misses-0_02-revenue-line\" target=\"_blank\">Q4 earnings miss</a>, as Wall Street focuses instead on free cash flow generation and improved earnings.</li><li>WFT  reported a Q4 loss of $0.14/share, larger than analyst consensus by better than the $0.33/share loss from a year earlier.</li><li>Despite adding to WFT's string of four years of losses, analysts see the quarter's results as <a href=\"https://www.reuters.com/article/us-weatherford-results/shares-of-weatherford-jump-as-wall-street-shrugs-off-earnings-miss-idUSKCN1PQ4OV\" target=\"_blank\">neutral to positive</a>, pointing to $210M in adjusted EBITDA and $65M of free cash flow.</li><li>WFT \"was able to continue to execute its transformation initiatives despite a volatile commodity price environment in the fourth quarter and post positive free cash flow,\" Evercore ISI writes.</li><li>The company says it expects a single digit revenue decline in Q1 2019 vs. Q4 2018, driven in part by seasonality, the sale of its land rigs in the Middle East and lower producer spending on weaker oil prices.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428726\" data-linked=\"Weatherford +22% as investors ignore Q4 miss, focus on free cash flow\" data-tweet=\"$WFT $WFTIQ - Weatherford +22% as investors ignore Q4 miss, focus on free cash flow https://seekingalpha.com/news/3428726-weatherfordplus-22-investors-ignore-q4-miss-focus-on-free-cash-flow?source=tweet\" data-url=\"https://seekingalpha.com/news/3428726-weatherfordplus-22-investors-ignore-q4-miss-focus-on-free-cash-flow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428724\" data-ts=\"1549038753\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MINI\" target=\"_blank\">MINI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428724-mobile-mini-down-7-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mobile Mini down 7% post Q4 results</a></h4><ul><li>Mobile Mini (<a href='https://seekingalpha.com/symbol/MINI' title='Mobile Mini, Inc.'>MINI</a> <font color=\"red\">-7.5%</font>) reported Q4 revenues growth of 9.7% Y/Y to $160.87M, with rental revenues of $152.05M (+9.8% Y/Y) and Sales revenue of $8.65M (13.5% Y/Y).</li><li>Storage Solutions revenues $129.44M (+8.4% Y/Y), operating margin of 30.4% <font color=\"green\">up by 55 bps</font>; and Adj. EBITDA margin of 40.4% <font color=\"green\">up by 90 bps</font>.</li><li>Storage Solution average units on rent +2.7% Y/Y, with average unit utilization of 85.2% during the quarter.</li><li>Tank &amp; Pump Solutions revenues $31.32M (+15.1% Y/Y), operating margin of 13.5% <font color=\"green\">up by 515 bps</font>; and Adj. EBITDA margin of 35% <font color=\"green\">up by 450 bps</font>.</li><li>Tank &amp; Pump Solutions average OEC utilization for the quarter was up by 300 bps to 76% Y/Y.</li><li>Q4 Operating margin <font color=\"red\">declined by 103 bps</font> to 24.2%.</li><li>Q4 Adj. EBITDA increased 13.7% Y/Y to $63.26M and margin <font color=\"green\">expanded by 141 bps</font> to 39.3%.</li><li>Net cash provided by operating activities for the quarter was $43.88M, compared to $39.81M a year ago. Free cash flow of $ 24.87M.</li><li>Company had Cash and cash equivalents of $5.61M, as of December 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428524-mobile-mini-misses-0_04-beats-revenue\" target=\"_blank\">Mobile Mini misses by $0.04, beats on revenue</a> (Feb. 1)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428514-mobile-mini-declares-0_275-dividend\" target=\"_blank\">Mobile Mini declares $0.275 dividend</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428724\" data-linked=\"Mobile Mini down 7% post Q4 results\" data-tweet=\"$MINI - Mobile Mini down 7% post Q4 results https://seekingalpha.com/news/3428724-mobile-mini-down-7-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428724-mobile-mini-down-7-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428722\" data-ts=\"1549038075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPAY\" target=\"_blank\">EPAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428722-bottomlineminus-17-on-downside-guides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bottomline -17% on downside guides</a></h4><ul><li>Bottomline Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/EPAY' title='Bottomline Technologies, Inc.'>EPAY</a>) <font color=\"red\">plunges 16.8%</font> after yesterday's Q2 results beat on revenue with 10% Y/Y growth but met on EPS and included downside guidance.</li><li>Q3 guidance has revenue of $103M to $105M (consensus: $107.7M) with Subscription and Transaction revenue of $74M to $76M (consensus: $77.1M).</li><li>Lowered FY19 guidance has revenue of $415M to $420M (consensus: $425.7M; was: $420M to $425M) and core EPS of $1.27 to $1.32 (consensus: $1.44; was: $1.41 to $1.45).</li><li><a href=\"https://seekingalpha.com/pr/17398407-bottomline-technologies-reports-second-quarter-results\" target=\"_blank\">Press release</a>/<a href=\"https://www.bottomline.com/application/files/3915/4896/9271/20190131-Bottomline-Investor-Presentation-Q2-19_Final.pdf\" target=\"_blank\">Presentation</a>/<a href=\"https://seekingalpha.com/article/4237338-bottomline-technologies-inc-epay-ceo-rob-eberle-q2-2019-results-earnings-call-transcript\" target=\"_blank\">Call transcript</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3428330-bottomline-technologies-eps-line-beats-revenue\" target=\"_blank\">Bottomline Technologies EPS in-line, beats on revenue</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428722\" data-linked=\"Bottomline -17% on downside guides\" data-tweet=\"$EPAY - Bottomline -17% on downside guides https://seekingalpha.com/news/3428722-bottomlineminus-17-on-downside-guides?source=tweet\" data-url=\"https://seekingalpha.com/news/3428722-bottomlineminus-17-on-downside-guides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428719\" data-ts=\"1549037062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMT\" target=\"_blank\">WMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428719-retail-royalty-tracks-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail royalty tracks lower</a></h4><ul> <li>Walmart (NYSE:<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a>) is <font color=\"red\">down 2.80%</font> to stand as the leading decliner in the Dow, while Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) is <font color=\"red\">off 3.3%</font> and Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) is <font color=\"red\">2.3% lower</font>.</li> <li>The moves could be tied to today's consumer sentiment report, which came in weaker than at any time since President Trump was elected. It also can't be ignored that Amazon reported disappointed earnings yesterday by its standards and warned on margin pressures.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428459-amazon-turns-lower-cfo-tackles-margin-india-call\" target=\"_blank\">Amazon turns lower as CFO tackles margin, India on call</a> (Jan. 31)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428376-amazon-reports-holiday-beats-aws-plus-46-percent\" target=\"_blank\">Amazon reports holiday beats; AWS +46%</a> (Jan. 31)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3428719\" data-linked=\"Retail royalty tracks lower\" data-tweet=\"$WMT $WMT $TGT - Retail royalty tracks lower https://seekingalpha.com/news/3428719-retail-royalty-tracks-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3428719-retail-royalty-tracks-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428718\" data-ts=\"1549036990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428718-titan-pharmaceuticals-leads-healthcare-gainers-cti-biopharma-and-diplomat-pharmacy-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Titan Pharmaceuticals leads healthcare gainers; CTI BioPharma and Diplomat Pharmacy among losers</a></h4><ul><li><b>Gainers: </b>Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) <font color=\"green\">+43%</font>. Regional Health Properties (NYSEMKT:<a href='https://seekingalpha.com/symbol/RHE' title='Regional Health Properties, Inc.'>RHE</a>) <font color=\"green\">+14%</font>. Zynerba Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals'>ZYNE</a>) <font color=\"green\">+11%</font>. Synlogic (NASDAQ:<a href='https://seekingalpha.com/symbol/SYBX' title='Synlogic, Inc.'>SYBX</a>) <font color=\"green\">+10%</font>. Coherus BioSciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CHRS' title='Coherus BioSciences'>CHRS</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a>) <font color=\"red\">-23%</font>. Nuvectra (NASDAQ:<a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a>) <font color=\"red\">-17%</font>. CTI BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a>) <font color=\"red\">-16%</font>. Surmodics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRDX' title='Surmodics, Inc.'>SRDX</a>) <font color=\"red\">-10%</font>. Diplomat Pharmacy (NYSE:<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy'>DPLO</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428718\" data-linked=\"Titan Pharmaceuticals leads healthcare gainers; CTI BioPharma and Diplomat Pharmacy among losers\" data-tweet=\"$TTNP $TTNP $RHE - Titan Pharmaceuticals leads healthcare gainers; CTI BioPharma and Diplomat Pharmacy among losers https://seekingalpha.com/news/3428718-titan-pharmaceuticals-leads-healthcare-gainers-cti-biopharma-and-diplomat-pharmacy-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3428718-titan-pharmaceuticals-leads-healthcare-gainers-cti-biopharma-and-diplomat-pharmacy-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428713\" data-ts=\"1549036072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428713-papa-johnsminus-8-full-sale-sliced-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s -8% with full sale sliced down</a></h4><ul> <li>Papa John's International (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) is <font color=\"red\">down 8.1%</font> after Reuters <a href=\"https://uk.reuters.com/article/us-papa-john-s-investment-exclusive/exclusive-papa-johns-seeks-investment-after-it-abandons-outright-sale-sources-idUKKCN1PQ55H\" target=\"_blank\">reports</a> that the company is only looking to sell off a slice of itself after acquisition offers from PE firms disappointed.</li> <li>Analysts have called the 30% stake held by ex-CEO John Schnatter a trouble spot for the company in moving forward cleanly.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3428713\" data-linked=\"Papa John&#39;s -8% with full sale sliced down\" data-tweet=\"$PZZA - Papa John&#39;s -8% with full sale sliced down https://seekingalpha.com/news/3428713-papa-johnsminus-8-full-sale-sliced-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3428713-papa-johnsminus-8-full-sale-sliced-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428712\" data-ts=\"1549035869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SF\" target=\"_blank\">SF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428712-stifelplus-3_4-higher-interest-rates-boost-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel +3.4% as higher interest rates boost Q4 results</a></h4><ul><li>Stifel Financial (NYSE:<a href='https://seekingalpha.com/symbol/SF' title='Stifel Financial Corporation'>SF</a>)<font color=\"green\"> gains 3.4%</font> after <a href=\"https://seekingalpha.com/pr/17398785-stifel-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4 adjusted EPS</a> of $1.57 beats the consensus estimate by a healthy 10 cents as higher interest rates boosts net interest income to a record.</li><li>Compares with $1.47 in the year-ago quarter.</li><li>Q4 net interest income of $126.7M rose 4.4% Q/Q and 19% Y/Y due to growth of interest-earning assets and interest-bearing liabilities as well as higher interest rates.</li><li>Q4 pretax adjusted operating margin of 21.9% vs. 20.1%.</li><li>Q4 compensation ratio of 56.0% vs. 60.0%.</li><li>Brokerage revenue of $248.5M rose 3% Q/Q and fell 6.6% Y/Y.</li><li>Investment banking revenue of $201.2M rose 19% Q/Q and fell 14% Y/Y.</li><li>Asset management and service fees of $210.1M rose 4.6% Q/Q and 13% Y/Y.</li><li>Interest revenue of $184.5M increased 8.7% from Q3 and 46% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428504-stifel-financial-beats-0_10-beats-revenue\" target=\"_blank\">Stifel Financial beats by $0.10, beats on revenue</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428712\" data-linked=\"Stifel +3.4% as higher interest rates boost Q4 results\" data-tweet=\"$SF - Stifel +3.4% as higher interest rates boost Q4 results https://seekingalpha.com/news/3428712-stifelplus-3_4-higher-interest-rates-boost-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428712-stifelplus-3_4-higher-interest-rates-boost-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428709\" data-ts=\"1549035800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKYW\" target=\"_blank\">SKYW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428709-skywestplus-3_7-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SkyWest +3.7% post Q4 results</a></h4><div><ul><li>SkyWest (<a href='https://seekingalpha.com/symbol/SKYW' title='SkyWest, Inc.'>SKYW</a> <font color=\"green\">+3.7%</font>) reports <a href=\"https://seekingalpha.com/pr/17398370-skywest-inc-announces-fourth-quarter-2018-profit\" target=\"_blank\">Q4</a> revenue growth of 4.2% Y/Y to $803.5M.</li><li>Since Q4 2017, SkyWest added 39 new E175 aircraft and five new CRJ900 aircraft, while removing 48 older aircraft from its fleet.</li><li>Operating expenses were up slightly to $682M, due to higher fuel costs and increased labor costs.</li><li>SkyWest announced a new flying contract with Delta to acquire nine new E175s and operate the aircraft for a 9-year term.</li><li>Flight completion rates: Adjusted Completion 99.9%; Raw Completion 99%.</li><li>SkyWest had $689M in cash and marketable securities, down from $705M at September 30, 2018.</li><li>Total debt was $3.2B, up $51M Q/Q, which included debt issued for eight E175 aircraft acquired during the quarter, partially offset by scheduled principal payments.</li><li>\u201cWe look forward to moving ahead as one airline in 2019 as we continue to reduce risk, increase flexibility and ensure we're best positioned for continued opportunities.\" said Chip Childs, CEO and President of SkyWest.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428322-skywest-beats-0_26-beats-revenue\" target=\"_blank\">SkyWest beats by $0.26, beats on revenue</a> (Jan. 31)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3428709\" data-linked=\"SkyWest +3.7% post Q4 results\" data-tweet=\"$SKYW - SkyWest +3.7% post Q4 results https://seekingalpha.com/news/3428709-skywestplus-3_7-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428709-skywestplus-3_7-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428708\" data-ts=\"1549035583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFLY\" target=\"_blank\">SFLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428708-shutterflyminus-2_7-on-suntrust-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shutterfly -2.7% on SunTrust cut</a></h4><ul><li>SunTrust lowers its Shutterfly (NASDAQ:<a href='https://seekingalpha.com/symbol/SFLY' title='Shutterfly, Inc.'>SFLY</a>) target from $90 to $70 but maintains a Buy rating ahead of earnings.</li><li>The firm cites checks suggesting revenue will drop 1% in the quarter instead of the guided 5% growth. But the current valuation already mostly reflects the slowing revenue.</li><li>Shutterfly is expected to report earnings on February 5.</li><li>SFLY is <font color=\"red\">down 2.7%</font> to $44.73.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428708\" data-linked=\"Shutterfly -2.7% on SunTrust cut\" data-tweet=\"$SFLY - Shutterfly -2.7% on SunTrust cut https://seekingalpha.com/news/3428708-shutterflyminus-2_7-on-suntrust-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3428708-shutterflyminus-2_7-on-suntrust-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428704\" data-ts=\"1549034984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MATW\" target=\"_blank\">MATW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428704-matthews-international-down-8-post-q1-results-reaffirms-fy19-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Matthews International down 8% post Q1 results; reaffirms FY19 guidance</a></h4><ul><li>Matthews International (<a href='https://seekingalpha.com/symbol/MATW' title='Matthews International Corporation'>MATW</a> <font color=\"red\">-8.7%</font>) reported Q1 sales of $374.18M (+1.3% Y/Y), reflecting organic sales growth in Memorialization and Industrial Technologies segments.</li><li>Sales by Segment: SGK Brand Solutions $185.3M (-3.4% Y/Y); Memorialization $153.88M (+6.2% Y/Y); and Industrial Technologies $34.99M (+6.7% Y/Y).</li><li>Q1 Gross margin <font color=\"red\">declined by 180 bps</font> to 33.8%; and operating margin<font color=\"red\"> declined by 90 bps</font> to 4.2%.</li><li>Adj. EBITDA was $46.48M almost similar to last year same quarter and margin <font color=\"red\">declined by 20 bps</font> to 12.4%.</li><li>Company repurchased ~186,400 shares under its repurchase program during the quarter.</li><li>Net cash provided by operating activities for the quarter was $8.38M, compared to $7.36M a year ago.</li><li>Company maintains their targets for FY19 to achieve growth in adjusted EBITDA in the mid-to-high single digit percentage range; growth in non-GAAP earnings per share in the mid-single digit percentage; and expects to generate higher operating cash flow in fiscal 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428365-matthews-misses-0_07-revenue-line\" target=\"_blank\">Matthews misses by $0.07,  revenue in-line</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428704\" data-linked=\"Matthews International down 8% post Q1 results; reaffirms FY19 guidance\" data-tweet=\"$MATW - Matthews International down 8% post Q1 results; reaffirms FY19 guidance https://seekingalpha.com/news/3428704-matthews-international-down-8-post-q1-results-reaffirms-fy19-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3428704-matthews-international-down-8-post-q1-results-reaffirms-fy19-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428700\" data-ts=\"1549034338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428700-sonyminus-8-after-fq3-results-fall-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sony -8% after FQ3 results fall short</a></h4><ul> <li>Sony (NYSE:<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a>) is <font color=\"red\">down 8.1%</font> in morning trading after FQ3 revenue trailed estimates slightly (¥2.4T vs. ¥2.6T) to take the shine off a guidance hike for FY19 profit of ¥835T from ¥705T.</li> <li>Profit in Sony's gaming business fell in FQ3 to ¥73.1B from ¥85.4B a year ago, while a gain booked from the EMI deal boosted music business profit to ¥147B from ¥39.3B a year ago. Overall profit came in at ¥377T vs. ¥384T anticipated.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3428523-sony-reports-q3-eps-330_77\" target=\"_blank\">Sony reports Q3 EPS of ¥330.77</a> (Feb. 1)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428700\" data-linked=\"Sony -8% after FQ3 results fall short\" data-tweet=\"$SNE - Sony -8% after FQ3 results fall short https://seekingalpha.com/news/3428700-sonyminus-8-after-fq3-results-fall-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3428700-sonyminus-8-after-fq3-results-fall-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428691\" data-ts=\"1549033305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYL\" target=\"_blank\">TYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428691-tyler-techplus-1-on-micropact-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyler Tech +1% on MicroPact acquisition</a></h4><ul><li>Tyler Technologies (NYSE:<a href='https://seekingalpha.com/symbol/TYL' title='Tyler Technologies, Inc.'>TYL</a>) <a href=\"https://www.businesswire.com/news/home/20190201005032/en/Tyler-Technologies-Acquire-MicroPact-Arlington-Capital-Partners\" target=\"_blank\">will acquire</a> MicroPact from Arlington Capital Partners for $185M in cash. The transaction is expected to close on March 15.</li><li>MicroPact provides case management and business process management applications for government agencies. The company has 469 employees and over $70M in annual revenue.</li><li>TYL is up 1% to $191.03.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428691\" data-linked=\"Tyler Tech +1% on MicroPact acquisition\" data-tweet=\"$TYL - Tyler Tech +1% on MicroPact acquisition https://seekingalpha.com/news/3428691-tyler-techplus-1-on-micropact-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3428691-tyler-techplus-1-on-micropact-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428683\" data-ts=\"1549032895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WAIR\" target=\"_blank\">WAIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428683-wesco-aircraft-holdings-slides-12_7-due-to-weak-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wesco Aircraft Holdings slides 12.7% due to weak margins</a></h4><div><ul><li>Wesco Aircraft (<a href='https://seekingalpha.com/symbol/WAIR' title='Wesco Aircraft Holdings'>WAIR</a> <font color=\"red\">-12.7%</font>) reports <a href=\"https://seekingalpha.com/pr/17398446-wesco-aircraft-holdings-reports-fiscal-2019-first-quarter-results\" target=\"_blank\">Q1</a> revenue growth of 8.9% Y/Y to $395.31M.</li><li>Overall Q1 margins: Gross <font color=\"red\">declined 113 bps</font> to 24.9%, the increase was primarily due to higher sales volume, partially offset by a decline in margin; operating <font color=\"red\">declined 118 bps</font> to 5.6% &amp; adj. EBITDA <font color=\"red\">declined 18 bps</font> to 9.5%.</li><li>SG&amp;A expenses totaled $76.3M (+9.2% Y/Y) the increase was primarily due to costs associated with the company\u2019s Wesco 2020 initiatives, totaling $8M.</li><li>Net cash provided by operating activities totalled $32.4M &amp; FCF was $34.7M, compared Y/Y with negative $31.2M.</li><li><b>FY 2019 outlook:</b> Expect net sales to increase at a mid-single-digit percentage pace compared to fiscal 2018; due to, higher sales volume, Wesco 2020 benefits and expense leverage are expected to drive a high-single-digit percentage increase in adj. EBITDA.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428361-wesco-aircraft-beats-0_01-beats-revenue\" target=\"_blank\">Wesco Aircraft beats by $0.01, beats on revenue</a> (Jan. 31)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3428683\" data-linked=\"Wesco Aircraft Holdings slides 12.7% due to weak margins\" data-tweet=\"$WAIR - Wesco Aircraft Holdings slides 12.7% due to weak margins https://seekingalpha.com/news/3428683-wesco-aircraft-holdings-slides-12_7-due-to-weak-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3428683-wesco-aircraft-holdings-slides-12_7-due-to-weak-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428682\" data-ts=\"1549032682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTX\" target=\"_blank\">LPTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428682-leap-therapeutics-down-24-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leap Therapeutics down 24% on equity offering</a></h4><ul><li>Thinly traded nano cap Leap Therapeutics (<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a> <font color=\"red\">-23.6%</font>) slumps on more than a 9x surge in volume in reaction to its <a href=\"https://seekingalpha.com/pr/17399167-leap-therapeutics-announces-pricing-11_5-million-public-offering-common-stock-warrants\" target=\"_blank\">public offering</a> of ~6.6M shares of common stock and warrants to purchase up to the same number shares at a combined price of $1.75. Gross proceeds should be ~$11.5M.</li><li>The seven-year warrants are exercisable at $1.95 per common share.</li><li>Closing date is February 5.</li><li>Yesterday's close was $1.95.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428682\" data-linked=\"Leap Therapeutics down 24% on equity offering\" data-tweet=\"$LPTX - Leap Therapeutics down 24% on equity offering https://seekingalpha.com/news/3428682-leap-therapeutics-down-24-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3428682-leap-therapeutics-down-24-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428675\" data-ts=\"1549032123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WKULF\" target=\"_blank\">WKULF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428675-weekend-unlimited-changing-ticker-to-pot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekend Unlimited changing ticker to &#39;POT&#39;</a></h4><ul><li>Canadian marijuana player Weekend Unlimited (<a href='https://seekingalpha.com/symbol/WKULF' title='Weekend Unlimited Inc.'>OTCPK:WKULF</a>) has won the lottery, of sorts, <a href=\"https://finance.yahoo.com/news/pot-stock-ticker-weekend-unlimited-080500392.html\" target=\"_blank\">securing permission to</a> take over the \"POT\" symbol (in Toronto) previously owned by Potash (which is now Nutrien after merging with Agrium).</li><li>Weekend Unlimited currently trades under the ticker YOLO, but will switch to POT on Monday.</li><li>Shares are <font color=\"green\">up more than 50%</font> in Toronto action.</li><li>Related ETF: <a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428675\" data-linked=\"Weekend Unlimited changing ticker to &#39;POT&#39;\" data-tweet=\"$WKULF $MJ - Weekend Unlimited changing ticker to &#39;POT&#39; https://seekingalpha.com/news/3428675-weekend-unlimited-changing-ticker-to-pot?source=tweet\" data-url=\"https://seekingalpha.com/news/3428675-weekend-unlimited-changing-ticker-to-pot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428668\" data-ts=\"1549031739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428668-twilio-closes-sendgrid-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio closes SendGrid acquisition</a></h4><ul><li>Twilio (<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a> <font color='green'>+0.9%</font>) <a href=\"https://seekingalpha.com/pr/17399090-twilio-completes-acquisition-sendgrid\" target=\"_blank\">closes </a>its SendGrid (NYSE:<a href='https://seekingalpha.com/symbol/SEND' title='SendGrid, Inc.'>SEND</a>) acquisition, a deal valued at approximately $3B.</li><li>Based on yesterday's Twilio closing price, SendGrid investors will receive approximately $53.99 of aggregate value per share.</li><li>SendGrid has now stopped trading on the NYSE.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428668\" data-linked=\"Twilio closes SendGrid acquisition\" data-tweet=\"$TWLO $TWLO $SEND - Twilio closes SendGrid acquisition https://seekingalpha.com/news/3428668-twilio-closes-sendgrid-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3428668-twilio-closes-sendgrid-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428651\" data-ts=\"1549030455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEDL\" target=\"_blank\">VEDL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428651-vedl-and-opk-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VEDL and OPK among premarket losers</a></h4><ul><li>Vedanta (NYSE:<a href='https://seekingalpha.com/symbol/VEDL' title='Vedanta Ltd'>VEDL</a>) <font color=\"red\">-17%</font> after Anglo American <a href=\"https://seekingalpha.com/news/3428588-vedanta-minus-18-percent-anglo-american-stake-purchase\" target=\"_blank\">stake purchase</a>.</li><li>MagneGas Applied Technology Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a>) <font color=\"red\">-16%</font> on <a href=\"https://seekingalpha.com/pr/17398980-magnegas-officially-rebranded-taronis-technologies-inc\" target=\"_blank\">rebranding</a> Taronis Technologies.</li><li>Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics'>LPTX</a>) <font color=\"red\">-12%</font> on planned <a href=\"https://seekingalpha.com/news/3428464-leap-therapeutics-minus-16-percent-planned-offering\" target=\"_blank\">offering</a>.</li><li>Corcept Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CORT' title='Corcept Therapeutics Incorporated'>CORT</a>) <font color=\"red\">-7%</font> on announcing <a href=\"https://seekingalpha.com/news/3428424-corcept-sees-q4-revenue-consensus-shares-3-percent-hours\" target=\"_blank\">preliminary</a> results.</li><li>OPKO Health (NYSEMKT:<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a>) <font color=\"red\">-6%</font> after<a href=\"https://seekingalpha.com/pr/17398703-opko-provides-update-development-opkminus-88004-selective-androgen-receptor-modulator\" target=\"_blank\"> </a>disappointing <a href=\"https://seekingalpha.com/news/3428558-opko-strikes-opkminus-88004-men-bph-shares-25-percent-premarket\" target=\"_blank\">results</a> from a Phase 2 trial evaluating OPK-88004 in men with enlarged prostate.</li><li>Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a>) <font color=\"red\">-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3428651\" data-linked=\"VEDL and OPK among premarket losers\" data-tweet=\"$VEDL $VEDL $TRNX - VEDL and OPK among premarket losers https://seekingalpha.com/news/3428651-vedl-and-opk-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428651-vedl-and-opk-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428650\" data-ts=\"1549030437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTNP\" target=\"_blank\">TTNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428650-gern-symc-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GERN, SYMC among premarket gainers</a></h4><ul><li>Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) <font color=\"green\">+77%</font> as it <a href=\"https://seekingalpha.com/news/3428465-titan-pharma-plus-43-percent-lauds-probuphine-relaunch\" target=\"_blank\">lauds</a> Probuphine relaunch.</li><li>ToughBuilt Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/TBLT' title='ToughBuilt Industries, Inc.'>TBLT</a>) <font color=\"green\">+40%</font> on <a href=\"https://seekingalpha.com/pr/17399094-toughbuilt-announces-agreement-major-european-distributor\" target=\"_blank\">agreement</a> with Toolbank.</li><li>Geron (NASDAQ:<a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/pr/17398467-geron-announces-expansion-leadership-team-appointment-chief-medical-officer\" target=\"_blank\">expansion</a> of its leadership team with the appointment of a new chief medical officer to support the Company\u2019s clinical drug development efforts in hematology-oncology.</li><li>Deckers Outdoor (NASDAQ:<a href='https://seekingalpha.com/symbol/DECK' title='Deckers Outdoor Corporation'>DECK</a>) <font color=\"green\">+8%</font> on Q3 <a href=\"https://seekingalpha.com/news/3428329-deckers-outdoor-beats-1_30-beats-revenue\" target=\"_blank\">results</a>.</li><li>Symantec (NASDAQ:<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a>) <font color=\"green\">+8%</font> on Q3 <a href=\"https://seekingalpha.com/news/3428360-symantec-beats-0_05-beats-revenue\" target=\"_blank\">results</a>.</li><li>Heat Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/HTBX' title='Heat Biologics, Inc.'>HTBX</a>) <font color=\"green\">+6%</font>.</li><li>Golden Ocean (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGL' title='Golden Ocean Group Limited'>GOGL</a>) <font color=\"green\">+6%</font>.</li><li>Blink Charging (NASDAQ:<a href='https://seekingalpha.com/symbol/BLNK' title='Blink Charging Co.'>BLNK</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428650\" data-linked=\"GERN, SYMC among premarket gainers\" data-tweet=\"$TTNP $TTNP $TBLT - GERN, SYMC among premarket gainers https://seekingalpha.com/news/3428650-gern-symc-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3428650-gern-symc-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428649\" data-ts=\"1549030417\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428649-chevronplus-1_6-q4-earnings-beat-estimates-production-jumps-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chevron +1.6% as Q4 earnings beat estimates, production jumps 12%</a></h4><ul><li>Chevron (NYSE:<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a>) <font color=\"green\">+1.6%</font> pre-market after beating <a href=\"https://seekingalpha.com/news/3428619-chevron-eps-1_95\" target=\"_blank\">Q4 earnings</a> expectations and posting a 13% Y/Y increase in revenues to $42.4B, helped by higher prices and production.</li><li>Also, CVX's board authorizes a new stock buyback program of as much as $25B.</li><li>Q4 net income of $3.7B, or $1.95/share, rose from $3.1B, or $1.64 a share, in the year-earlier quarter which had included $2.02B in tax benefits.</li><li>Q4 worldwide net oil equivalent production rose 12.4% Y/Y to 3.08M boe/day from 2.74M boe/day a year ago, while full-year total production rose more than 7% Y/Y to 2.93M boe/day, and the company expects 2019 output to rise 4%-7%, excluding the effect of asset sales.</li><li>CVX says it added 1.46B boe in proved reserves in 2018, mostly from the Permian Basin and LNG projects in Australia.</li><li>Q4 U.S. upstream operations earned $964M vs. $3.69B a year earlier, with the decrease primarily due to the absence of the prior-year benefit of $3.33B from U.S. tax reform; CVX says its average sales price per barrel of crude oil and natural gas liquids rose to $56 from $50 a year earlier, and its average sales price of natural gas rose to $2.01/Mcf from $1.86/Mcf a year ago.</li><li>International upstream operations in the quarter earned $2.33B vs. $1.6B a year ago, with the increase mainly due to higher natural gas sales volumes and prices; the company's average sales price per barrel for crude oil and natural gas liquids edged higher to $59 from $57 a year earlier, and the average sales price of natural gas jumped to $6.81/Mcf from $4.93/Mcf in the year-ago quarter.</li><li>Q4 U.S. downstream operations earned $256M vs. $1.2B a year earlier, with the decrease primarily due to the absence of the prior-year benefit of $1.16B from U.S. tax reform.</li><li>International downstream operations jumped to $603M from $84M a year ago, largely due to higher margins on refined product sales.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428649\" data-linked=\"Chevron +1.6% as Q4 earnings beat estimates, production jumps 12%\" data-tweet=\"$CVX - Chevron +1.6% as Q4 earnings beat estimates, production jumps 12% https://seekingalpha.com/news/3428649-chevronplus-1_6-q4-earnings-beat-estimates-production-jumps-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3428649-chevronplus-1_6-q4-earnings-beat-estimates-production-jumps-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428646\" data-ts=\"1549029977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428646-sangamo-up-2-premarket-ahead-of-data-readout-on-sbminus-913-and-sbminus-318\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo up 2% premarket ahead of data readout on SB-913 and SB-318</a></h4><ul><li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) is up <font color=\"green\">2%</font> premarket on light volume following its <a href=\"https://seekingalpha.com/pr/17399035-sangamo-therapeutics-host-conference-call-review-interim-results-phase-1-2-champions-empowers\" target=\"_blank\">announcement </a>that it will host a conference call on Thursday, February 7, at 12:30 pm ET to discuss preliminary data from the Phase 1/2 CHAMPIONS and EMPOWERS studies evaluating SB-913 and SB-318 in patients with mucopolysaccharidosis type II (MPS II) and MPS I, respectively.</li><li>The call will follow presentations at the WORLDSymposium in Orlando, FL.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428646\" data-linked=\"Sangamo up 2% premarket ahead of data readout on SB-913 and SB-318\" data-tweet=\"$SGMO - Sangamo up 2% premarket ahead of data readout on SB-913 and SB-318 https://seekingalpha.com/news/3428646-sangamo-up-2-premarket-ahead-of-data-readout-on-sbminus-913-and-sbminus-318?source=tweet\" data-url=\"https://seekingalpha.com/news/3428646-sangamo-up-2-premarket-ahead-of-data-readout-on-sbminus-913-and-sbminus-318\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428639\" data-ts=\"1549029615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WETF\" target=\"_blank\">WETF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428639-wisdomtreeminus-6-aum-slips-advisory-fee-rate-shrinks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WisdomTree -6% as AUM slips, advisory fee rate shrinks</a></h4><ul><li>WisdomTree Investments (NASDAQ:<a href='https://seekingalpha.com/symbol/WETF' title='WisdomTree Investments, Inc.'>WETF</a>) <font color=\"red\">sinks 6.0%</font> in premarket trading after<a href=\"https://seekingalpha.com/pr/17398887-wisdomtree-announces-fourth-quarter-2018-results\" target=\"_blank\"> Q4 adjusted EPS </a>of 6 cents misses the consensus estimate of 8 cents.</li><li>Compares with 9 cents in Q3 and 4 cents in the year-ago quarter.</li><li>Q4 adjusted operating margin of 21.9% falls from 30.5% in Q3, up from 16.5% in the year-ago quarter.</li><li>Assets under management of $54.1B fell 8.5% from Sept. 30, 2018; Q4 net inflows of $200M compares with outflows of $1.3B in Q3 and inflows of $300M in Q4 2017.</li><li>Average advisory fee rate of 0.47% ticks down from 0.48% in Q3 and 0.50% in Q4 2017.</li><li>U.S. listed ETF AUM was $35.5B at Dec. 31, 2018, down 15% from Sept. 30, 2018 due to market depreciation and net outflows; international listed ETP AUM of $18.6B at the quarter-end rose 5.8% from Q3-end due to net inflows.</li><li><a href=\"https://www.globenewswire.com/Tracker?data=MKtueQ8C1PDfC0clO32HXiPnLsOEGHldEMZ0Mql-jyoFirzKHnW0MfWaQuNyQLXkZU3ZCB3Kv0sR1Js6dEesJ9Bhnayfv5uTX0DQiPNJp8w=\" target=\"_blank\">Conference call</a> at 9:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428547-wisdomtree-investments-misses-0_02-revenue-line\" target=\"_blank\">WisdomTree Investments misses by $0.02,  revenue in-line</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428639\" data-linked=\"WisdomTree -6% as AUM slips, advisory fee rate shrinks\" data-tweet=\"$WETF - WisdomTree -6% as AUM slips, advisory fee rate shrinks https://seekingalpha.com/news/3428639-wisdomtreeminus-6-aum-slips-advisory-fee-rate-shrinks?source=tweet\" data-url=\"https://seekingalpha.com/news/3428639-wisdomtreeminus-6-aum-slips-advisory-fee-rate-shrinks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428628\" data-ts=\"1549028843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428628-jobs-headline-beat-misses-underneath\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jobs: Headline beat, but some misses underneath</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3428615-january-job-gain-304k-blows-estimates\" target=\"_blank\">Alongside January's 304K job gain</a>, November's print was revised higher by 20K to 196K, but December's was trimmed by a whopping 90K to 222K. The last three months have now seen an average job gain of 241K.</li><li>The unemployment rate unexpectedly ticked higher to 4.0% thanks to a jump in the labor force participation rate to 63.2% from 63.1%. The broader U6 unemployment rate rose to 8.1% from 7.6%. A year ago, it was 8.1%.</li><li>Turning back to the household data, average weekly hours were flat at 34.5, and average hourly earnings edged up 0.1% vs. 0.3% expected. On a year-over-year basis, average hourly earnings were up 3.2%, inline with estimates.</li><li>So the headline number was a big beat, but past months' downward revisions were sizable, and average hourly earnings were well shy of estimates. Nevertheless, we'll call the report a beat. More importantly, unless the Fed knows something we don't (and they don't), folks may be scratching their heads on the central bank's big dovish turn this week.</li><li>Turning to markets, U.S. stock index futures have risen a bit since the 8:30 ET print, with the Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='Invesco QQQ ETF'>QQQ</a>) now <font color=\"red\">down 0.5%</font> and the S&amp;P 500 flat. Gold (NYSEARCA:<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>) has shed a few dollars, now <font color=\"red\">down 0.2%</font>, and the dollar (<a href='https://seekingalpha.com/symbol/UUP' title='Invesco DB USD Bullish ETF'>UUP</a>, <a href='https://seekingalpha.com/symbol/UDN' title='Invesco DB US Dollar Index Bearish ETF'>UDN</a>) has moved both up and then down, now back to flat on the session.</li><li>The 10-year Treasury yield is now up one basis point for the day to 2.64%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"red\">-0.2%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"green\">+0.4%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3428628\" data-linked=\"Jobs: Headline beat, but some misses underneath\" data-tweet=\"$QQQ $GLD $UUP - Jobs: Headline beat, but some misses underneath https://seekingalpha.com/news/3428628-jobs-headline-beat-misses-underneath?source=tweet\" data-url=\"https://seekingalpha.com/news/3428628-jobs-headline-beat-misses-underneath\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428627\" data-ts=\"1549028821\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARW\" target=\"_blank\">ARW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428627-stifel-steps-to-arrow-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel steps to Arrow sidelines</a></h4><ul><li>Stifel downgrades Arrow Electronics (NYSE:<a href='https://seekingalpha.com/symbol/ARW' title='Arrow Electronics Inc'>ARW</a>) from Buy to Hold and drops the target from $85 to $80, a 5% upside.</li><li>Arrow is expected to report earnings on February 7. Consensus <a href=\"https://seekingalpha.com/symbol/ARW/earnings\" target=\"_blank\">estimates</a> have revenue at $7.94B and EPS at $2.56.</li><li>Arrow shares are <font color=\"red\">down 0.8%</font> premarket to $75.33. Shares are <font color=\"green\">up 17%</font> in the past quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428627\" data-linked=\"Stifel steps to Arrow sidelines\" data-tweet=\"$ARW - Stifel steps to Arrow sidelines https://seekingalpha.com/news/3428627-stifel-steps-to-arrow-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3428627-stifel-steps-to-arrow-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428626\" data-ts=\"1549028656\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZBH\" target=\"_blank\">ZBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428626-zimmer-biomet-beats-q4-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zimmer Biomet beats Q4 consensus</a></h4><ul><li>Zimmer Biomet (<a href='https://seekingalpha.com/symbol/ZBH' title='Zimmer Biomet Holdings, Inc.'>ZBH</a>) <a href=\"https://seekingalpha.com/pr/17398814-zimmer-biomet-announces-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4 results</a>: Revenues: $2,071M (+0.1%).</li><li>Knees: $729.5M (-0.1%); Hips: $497.7M (+0.1%); S.E.T: $461.1M (+1.9%); Dental: $104.4M (-3.0%); Spine &amp; CMF: $197.7M (+2.1%); Other: $80.6M (-7.5%).</li><li>Net Loss: ($901.1M); Non-GAAP Net Income: $447.9M (+4.5%); Loss Per Share: ($4.42); Non-GAAP EPS: $2.18 (+3.8%); CF Flow Ops: $1,747.4M (+10.4%).</li><li>The consensus non-GAAP EPS and Revenue estimate were $2.17 and $2.06B, respectively.</li><li>Shares are up <font color=\"green\">1%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428502-zimmer-biomet-beats-0_01-beats-revenue\" target=\"_blank\">Zimmer Biomet beats by $0.01, beats on revenue</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428626\" data-linked=\"Zimmer Biomet beats Q4 consensus\" data-tweet=\"$ZBH - Zimmer Biomet beats Q4 consensus https://seekingalpha.com/news/3428626-zimmer-biomet-beats-q4-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3428626-zimmer-biomet-beats-q4-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428625\" data-ts=\"1549028621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428625-exxonplus-2-q4-earnings-top-estimates-on-big-refining-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon +2% as Q4 earnings top estimates on big refining boost</a></h4><ul><li>Exxon Mobil (NYSE:<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a>) <font color=\"green\">+2.2%</font> pre-market after <a href=\"https://seekingalpha.com/news/3428589-exxon-mobil-beats-0_23-misses-revenue\" target=\"_blank\">Q4 earnings</a> beat Wall Street expectations and oil and natural gas production edged higher.</li><li>Q4 earnings were $6B, or $1.41/share assuming dilution, compared with $8.4B in the prior-year quarter, but Q4 earnings excluding U.S. tax reform and impairments were $6.4B vs. $3.7B in the prior-year quarter.</li><li>XOM says Q4 production rose 4.8% Y/Y to 4.01M boe/day, roughly in line with expectations and topping the 4M-barrel level for the <a href=\"https://finance.yahoo.com/news/exxon-bounces-back-crude-oil-130446928.html\" target=\"_blank\">first time in nearly two years</a>, with Permian Basin output soaring 90%, and total revenue rose 8% Y/Y to $71.9B but fell short of analyst consensus of ~$72.5B.</li><li>Q4 upstream earnings fell 6.2% Q/Q to $3.71B vs. $3.96B in the prior quarter, hurt by lower liquids prices and higher expenses, Q4 downstream earnings surged 64.4% to $2.73B from $1.66B, driven by higher margins capturing crude differentials and higher divestment gains including the sale of the Augusta refinery.</li><li>CEO Darren Woods is expected to make his debut on a quarterly conference call at 9:30 a.m. ET; he would become XOM's first CEO to field questions on an earnings conference call in at least 15 years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428625\" data-linked=\"Exxon +2% as Q4 earnings top estimates on big refining boost\" data-tweet=\"$XOM - Exxon +2% as Q4 earnings top estimates on big refining boost https://seekingalpha.com/news/3428625-exxonplus-2-q4-earnings-top-estimates-on-big-refining-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3428625-exxonplus-2-q4-earnings-top-estimates-on-big-refining-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428623\" data-ts=\"1549028409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428623-snapplus-1_6-on-upgrade-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap +1.6% on upgrade to sidelines</a></h4><ul><li>Cascend Securities upgrades Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) from Sell to Hold citing checks that show Snapchat's Android ratings recovering, indicating that the app redesign \"nightmare\" is over.</li><li>SNAP is <font color=\"green\">up 1.6%</font> premarket to $6.78.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428623\" data-linked=\"Snap +1.6% on upgrade to sidelines\" data-tweet=\"$SNAP - Snap +1.6% on upgrade to sidelines https://seekingalpha.com/news/3428623-snapplus-1_6-on-upgrade-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3428623-snapplus-1_6-on-upgrade-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428622\" data-ts=\"1549028292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WY\" target=\"_blank\">WY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428622-weyerhaeuserminus-4_7-after-q4-hurt-lower-wood-products-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weyerhaeuser -4.7% after Q4 hurt by lower wood products profit</a></h4><ul><li>Weyerhaeuser (NYSE:<a href='https://seekingalpha.com/symbol/WY' title='Weyerhaeuser Co.'>WY</a>)<font color=\"red\"> sinks 4.7%</font> in premarket trading after <a href=\"https://seekingalpha.com/pr/17398753-weyerhaeuser-reports-fourth-quarter-full-year-results\" target=\"_blank\">Q4 EPS, excluding special items, of 10 cents</a> misses consensus estimate by a penny.</li><li>Compares with 28 cents in Q3 and 31 cents in Q4 2017.</li><li>Q4 net sales of $1.64B misses consensus by $90M, falls from $1.91B in Q3 and $1.82B in Q4 2017.</li><li>\"Entering 2019, U.S. economic fundamentals remain strong and we expect continued growth in U.S. housing,\" says President and CEO Devin W. Stockfish.</li><li>Q4 adjusted EBITDA of $346M falls from $505M in Q3 and $551M in the year-ago quarter.</li><li>Q4 timberlands adjusted EBITDA fell to $188M from $206M in Q3 and sees Q1 earnings and adjusted EBITDA lower than Q4.</li><li>Q4 real estate, energy &amp; natural resources adjusted EBITDA of $90M rises from $86M in Q3; sees Q1 earnings and adjusted EBITDA higher due to timing of real estate transactions; sees full-year adjusted EBITDA about $260M.</li><li>Q4 wood products adjusted EBITDA of $66M falls from $250M in Q3; sees Q1 earnings and adjusted EBITDA significantly higher than Q4 on seasonally higher volumes, higher operating rates, and improved unit manufacturing costs.</li><li>Including after-tax charges of $163M, primarily from a non-cash settlement to reduce pension liabilities, Q4 net loss was 12 cents per share.</li><li><a href=\"https://seekingalpha.com/pr/17398753-weyerhaeuser-reports-fourth-quarter-full-year-results\" target=\"_blank\">Conference call </a>at 10:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428484-weyerhaeuser-misses-0_01-misses-revenue\" target=\"_blank\">Weyerhaeuser misses by $0.01, misses on revenue</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428622\" data-linked=\"Weyerhaeuser -4.7% after Q4 hurt by lower wood products profit\" data-tweet=\"$WY - Weyerhaeuser -4.7% after Q4 hurt by lower wood products profit https://seekingalpha.com/news/3428622-weyerhaeuserminus-4_7-after-q4-hurt-lower-wood-products-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3428622-weyerhaeuserminus-4_7-after-q4-hurt-lower-wood-products-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428620\" data-ts=\"1549028149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCS\" target=\"_blank\">ONCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428620-oncosec-up-2-on-tavo-keytruda-data-in-melanoma\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oncosec up 2% on TAVO + Keytruda data in melanoma</a></h4><ul><li>OncoSec Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>) is up <font color=\"green\">2%</font> premarket on light volume in reaction to its <a href=\"https://seekingalpha.com/pr/17398996-oncosec-provides-keynoteminus-695-clinical-update-outlines-2019-milestones\" target=\"_blank\">announcement </a>of updated data from the KEYNOTE-695 study evaluating the combination of TAVO (tavokinogene telseplasmid) and Merck's (NYSE:<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a>) Keytruda (pembrolizumab) in patients with metastatic/recurrent melanoma.</li><li>The preliminary overall response rate &#40;ORR&#41; was 24% (n=5/21), above the primary endpoint of 20%. There was one complete responder. All responders remain on study after 6 - 10 months. All failed prior treatment with Keytruda or Bristol-Myers Squibb's Opdivo (nivolumab).</li><li>A pivotal study assessing TAVO + Keytruda in recurrent/persistent cervical cancer should launch in H1. If all goes well, a U.S. marketing application will be filed in 2021.</li><li>Preliminary data from a study of TAVO + Keytruda in triple negative breast cancer should be available later this year.</li><li>Management will host a conference call this morning at 9:00 am ET to discuss its clinical activities and expected milestones this year.</li><li>The company says TAVO uses electroporation (ImmunoPulse) to deliver IL-12 into the tumor microenvironment which stimulates an immune response to the cancer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3405812-oncosec-56-percent-premarket-mid-stage-tavo-data\" target=\"_blank\">OncoSec down 56% premarket on mid-stage TAVO data</a> (Nov. 6, 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428620\" data-linked=\"Oncosec up 2% on TAVO + Keytruda data in melanoma\" data-tweet=\"$ONCS $ONCS $MRK - Oncosec up 2% on TAVO + Keytruda data in melanoma https://seekingalpha.com/news/3428620-oncosec-up-2-on-tavo-keytruda-data-in-melanoma?source=tweet\" data-url=\"https://seekingalpha.com/news/3428620-oncosec-up-2-on-tavo-keytruda-data-in-melanoma\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428619\" data-ts=\"1549028004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVX\" target=\"_blank\">CVX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428619-chevron-eps-of-1_95\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chevron EPS of $1.95</a></h4><ul><li>Chevron (NYSE:<a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a>): Q4 GAAP EPS of $1.95 may not be comparable to consensus of $1.85.</li><li>Revenue of $42.4B (+12.7% Y/Y) in-line.</li><li>Shares <font color=\"green\">+2.31%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17399032-chevron-reports-fourth-quarter-net-income-3_7-billion-annual-earnings-14_8-billion\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428619\" data-linked=\"Chevron EPS of $1.95\" data-tweet=\"$CVX - Chevron EPS of $1.95 https://seekingalpha.com/news/3428619-chevron-eps-of-1_95?source=tweet\" data-url=\"https://seekingalpha.com/news/3428619-chevron-eps-of-1_95\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428613\" data-ts=\"1549027649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWRE\" target=\"_blank\">GWRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428613-guidewireplus-2-on-goldmans-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guidewire +2% on Goldman&#39;s Buy</a></h4><ul><li>Goldman Sachs reinstates Guidewire Software (NYSE:<a href='https://seekingalpha.com/symbol/GWRE' title='Guidewire Software, Inc.'>GWRE</a>) with a Buy rating and $106 target, a 22% upside.</li><li>Guidewire is expected to report earnings on March 5. Consensus <a href=\"https://seekingalpha.com/symbol/GWRE/earnings\" target=\"_blank\">estimates</a> have revenue at $159.54M and EPS at $0.19.</li><li>GWRE is <font color=\"green\">up 2%</font> premarket to $88.39.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428613\" data-linked=\"Guidewire +2% on Goldman&#39;s Buy\" data-tweet=\"$GWRE - Guidewire +2% on Goldman&#39;s Buy https://seekingalpha.com/news/3428613-guidewireplus-2-on-goldmans-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3428613-guidewireplus-2-on-goldmans-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428604\" data-ts=\"1549027141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BERY\" target=\"_blank\">BERY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428604-berry-plastics-beat-estimates-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Berry Plastics beat estimates in Q1</a></h4><ul><li>Berry Plastics (NYSE:<a href='https://seekingalpha.com/symbol/BERY' title='Berry Plastics Group, Inc.'>BERY</a>) reports organic sales growth of 3% in <a href=\"https://seekingalpha.com/pr/17398966-berry-global-group-inc-reports-first-quarter-2019-results-reaffirms-2019-fiscal-year-guidance\" target=\"_blank\">Q1</a>.</li><li>Consumer Packaging net sales grew 9% to $601M.</li><li>Health, Hygiene, &amp; Specialties net sales increased 22% to $702M.</li><li>Engineered Materials net sales up 3% to $669M.</li><li>Gross margin rate down 60 bps to 17.9%.</li><li>SG&amp;A expense rate improved 30 bps to 6.3%.</li><li>Adjusted operating margin rate slipped 50 bps to 10.1%.</li><li>Operating EBITDA advanced 6.8% to $331M.</li><li><b>FY2019 Guidance</b>: Cash flow from operation: $1.04B; Adjusted free cash flow: $670M; Capex: $350M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428597-berry-plastics-beats-0_02-beats-revenue\" target=\"_blank\">Berry Plastics beats by $0.02, beats on revenue</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428604\" data-linked=\"Berry Plastics beat estimates in Q1\" data-tweet=\"$BERY - Berry Plastics beat estimates in Q1 https://seekingalpha.com/news/3428604-berry-plastics-beat-estimates-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3428604-berry-plastics-beat-estimates-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428602\" data-ts=\"1549026976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPK\" target=\"_blank\">OPK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428602-fda-oks-opkos-sangia-psa-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA OKs OPKO&#39;s Sangia PSA test</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17398955-opko-health-receives-fda-approval-point-care-sangia-psa-test-claros-1-analyzer\" target=\"_blank\">approves </a>OPKO Health's (NYSEMKT:<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a>) point-of-care Sangia Total Prostate Specific Antigen &#40;PSA&#41; Test performed on the Claros 1 Analyzer with a fingerstick blood sample.</li><li>Shares are down <font color=\"red\">27%</font> premarket modestly higher volume in reaction to <a href=\"https://seekingalpha.com/news/3428558-opko-strikes-opkminus-88004-men-bph-shares-25-percent-premarket\" target=\"_blank\">disappointing data</a> on OPK-88004 in BPH.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428602\" data-linked=\"FDA OKs OPKO&#39;s Sangia PSA test\" data-tweet=\"$OPK - FDA OKs OPKO&#39;s Sangia PSA test https://seekingalpha.com/news/3428602-fda-oks-opkos-sangia-psa-test?source=tweet\" data-url=\"https://seekingalpha.com/news/3428602-fda-oks-opkos-sangia-psa-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428601\" data-ts=\"1549026765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYOU\" target=\"_blank\">CYOU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428601-changyouminus-9-on-bumpy-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Changyou -9% on bumpy Q4 results</a></h4><ul><li>Changyou (NASDAQ:<a href='https://seekingalpha.com/symbol/CYOU' title='Changyou.com Limited'>CYOU</a>) <font color=\"red\">drops 8.6%</font> after it reports Q4 results that missed EPS estimates but narrowly beat on revenue despite the 18% Y/Y revenue drop.</li><li>Online game revenue was down 14% Y/Y to $94M. Ad revenue dropped 32% to $4M, cinema ads fell 30% to $18M, and internet value-added services dropped 55% to $2M.</li><li>Net income attributable to CYOU was $11M compared to the $34M from last year's quarter.</li><li>Average monthly active accounts of PC games were down 17% on the year and 13% on the quarter to 2M. Mobile game accounts were down 6% Y/Y and 22% Q/Q to 2.9M.</li><li>Active paying accounts for PC were up 13% Y/Y to 0.9M and mobile dropped 42% Y/Y to 0.7M.</li><li><a href=\"https://seekingalpha.com/pr/17398722-changyou-reports-fourth-quarter-2018-fiscal-year-2018-unaudited-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428482-changyou-com-misses-0_30-beats-revenue\" target=\"_blank\">Changyou.com misses by $0.30, beats on revenue</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428601\" data-linked=\"Changyou -9% on bumpy Q4 results\" data-tweet=\"$CYOU - Changyou -9% on bumpy Q4 results https://seekingalpha.com/news/3428601-changyouminus-9-on-bumpy-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428601-changyouminus-9-on-bumpy-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428595\" data-ts=\"1549026580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDY\" target=\"_blank\">RDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428595-dr-reddysplus-3-on-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dr. Reddy&#39;s +3% on Q3 results</a></h4><ul><li>Dr. Reddy's (<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a>) <a href=\"http://www.drreddys.com/media/751415/dr-reddys-earnings-release-q3-fy19.pdf\" target=\"_blank\">Q3 results</a>: Revenues: $553M (+1.1%).</li><li>Net Income: $70M (+45.8%); EPS: $0.42 (+44.8%).</li><li>The consensus EPS and Revenue estimate were $0.26 and $553.87M, respectively.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428522-dr-reddys-beats-0_16-misses-revenue\" target=\"_blank\">Dr. Reddy's beats by $0.16, misses on revenue</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428595\" data-linked=\"Dr. Reddy&#39;s +3% on Q3 results\" data-tweet=\"$RDY - Dr. Reddy&#39;s +3% on Q3 results https://seekingalpha.com/news/3428595-dr-reddysplus-3-on-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3428595-dr-reddysplus-3-on-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428591\" data-ts=\"1549026278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EARS\" target=\"_blank\">EARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428591-auris-up-15-premarket-on-loan-repayment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auris up 15% premarket on loan repayment</a></h4><ul><li>Auris Medical Holding AG (NASDAQ:<a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding'>EARS</a>) is up <font color=\"green\">15%</font> premarket on light volume in response to the complete <a href=\"https://seekingalpha.com/pr/17398911-auris-medical-announces-full-repayment-hercules-loan-facility\" target=\"_blank\">repayment </a>of $12.5M of borrowings under a loan facility with Hercules Capital.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428591\" data-linked=\"Auris up 15% premarket on loan repayment\" data-tweet=\"$EARS - Auris up 15% premarket on loan repayment https://seekingalpha.com/news/3428591-auris-up-15-premarket-on-loan-repayment?source=tweet\" data-url=\"https://seekingalpha.com/news/3428591-auris-up-15-premarket-on-loan-repayment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428589\" data-ts=\"1549026241\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428589-exxon-mobil-beats-0_23-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon Mobil beats by $0.23, misses on revenue</a></h4><ul><li>Exxon Mobil (NYSE:<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a>): Q4 GAAP EPS of $1.41 <span style=\"color:green\">beats by $0.23</span>.</li><li>Revenue of $71.9B (+8.1% Y/Y) <font color=\"red\">misses by $630M</font>.</li><li>Shares <font color=\"green\">+2.3%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17398937-exxonmobil-earns-20_8-billion-2018-6-billion-fourth-quarter\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428589\" data-linked=\"Exxon Mobil beats by $0.23, misses on revenue\" data-tweet=\"$XOM - Exxon Mobil beats by $0.23, misses on revenue https://seekingalpha.com/news/3428589-exxon-mobil-beats-0_23-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3428589-exxon-mobil-beats-0_23-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428588\" data-ts=\"1549026199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEDL\" target=\"_blank\">VEDL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428588-vedantaminus-18-after-anglo-american-stake-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vedanta -18% after Anglo American stake purchase</a></h4><ul><li>Vedanta (NYSE:<a href='https://seekingalpha.com/symbol/VEDL' title='Vedanta Ltd'>VEDL</a>) <font color=\"red\">-17.7%</font> pre-market and closes at its <a href=\"https://www.reuters.com/article/us-vedanta-stocks/indias-vedanta-shares-slump-after-anglo-american-stake-purchase-idUSKCN1PQ41K\" target=\"_blank\">lowest since September 2016</a> in Indian trade following news its Cairn India Holdings foreign subsidiary had paid $200M to buy a stake in miner Anglo American (<a href='https://seekingalpha.com/symbol/AAUKF' title='Anglo American plc'>OTCQX:AAUKF</a>, <a href='https://seekingalpha.com/symbol/AAUKY' title='Anglo American plc ADR'>OTCPK:AAUKY</a>).</li><li>Analysts say they are skeptical of the merits of the investment and question the potential returns, which depend on Anglo\u2019s stock price.</li><li>Vedanta Resources Chairman Anil Agarwal\u2019s decision last year to take the miner private was seen by some as a prelude to a potentially broader deal with bigger miner Anglo.</li><li>Vedanta on Thursday reported a 21% decline in quarterly profit but still beat analyst estimates.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428588\" data-linked=\"Vedanta -18% after Anglo American stake purchase\" data-tweet=\"$VEDL $VEDL $AAUKF - Vedanta -18% after Anglo American stake purchase https://seekingalpha.com/news/3428588-vedantaminus-18-after-anglo-american-stake-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3428588-vedantaminus-18-after-anglo-american-stake-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428580\" data-ts=\"1549026116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVO\" target=\"_blank\">NVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428580-novo-nordisk-up-3-on-strong-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novo Nordisk up 3% on strong Q4</a></h4><ul><li>Novo Nordisk (<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a>) <a href=\"https://www.novonordisk.com/bin/getPDF.2233033.pdf\" target=\"_blank\">Q4 results</a> &#40;DKK&#41;: Revenues: 29,732M (+6.2%); Diabetes care and obesity: 24,897M (+7.6%); Biopharmaceuticals: 4,835M (-0.3%).</li><li>Net Income: 8,497M (+3.0%); EPS: 3.53 (+5.1%); CF Flow Ops: 44,616M (+8.4%).</li><li>Long-acting insulin: 5,456M (-1%); Fast-acting insulin: 5,030M (+9%); Premix insulin: 2,438M (-7%); Human insulin: 2,178M (-9%); Total GLP-1: 7,492M (+19%); Obesity (Saxenda): 1,229M (+76%); Haemophilia: 2,478M (-10%); Growth disorders (Norditropin): 1,962M (+15%).</li><li><strong>2019 Guidance</strong>: Sales growth (in local currencies): 2% - 5%; Operating profit (in local currencies): 2% - 6%; CAPEX: Around DKK9B; Free cash flow: DKK29B - 34B.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428510-novo-nordisk-reports-q4-results\" target=\"_blank\">Novo Nordisk reports Q4 results</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428580\" data-linked=\"Novo Nordisk up 3% on strong Q4\" data-tweet=\"$NVO - Novo Nordisk up 3% on strong Q4 https://seekingalpha.com/news/3428580-novo-nordisk-up-3-on-strong-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3428580-novo-nordisk-up-3-on-strong-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428576\" data-ts=\"1549025749\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428576-cti-bio-down-8-premarket-on-withdrawal-of-pacritinib-application-in-europe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CTI Bio down 8% premarket on withdrawal of pacritinib application in Europe</a></h4><ul><li>Thinly traded nano cap CTI BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a>) slips <font color=\"red\">8% </font>premarket on light volume in reaction to the <a href=\"https://seekingalpha.com/pr/17398890-cti-biopharma-receives-results-chmp-oral-explanation-pacritinib-treatment-myelofibrosis\" target=\"_blank\">withdrawal </a>of its marketing application in Europe seeking approval for pacritinib for myelofibrosis. The company took action following discussions with the advisory group CHMP who indicated that it was likely to recommend against approval citing insufficient data supporting efficacy for the indication.</li><li>The company is staying the course with pacritinib, a kinase inhibitor, in myelofibrosis patients with severe thrombocytopenia. A Phase 3 trial should commence in Q3.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428576\" data-linked=\"CTI Bio down 8% premarket on withdrawal of pacritinib application in Europe\" data-tweet=\"$CTIC - CTI Bio down 8% premarket on withdrawal of pacritinib application in Europe https://seekingalpha.com/news/3428576-cti-bio-down-8-premarket-on-withdrawal-of-pacritinib-application-in-europe?source=tweet\" data-url=\"https://seekingalpha.com/news/3428576-cti-bio-down-8-premarket-on-withdrawal-of-pacritinib-application-in-europe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428575\" data-ts=\"1549025672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZUO\" target=\"_blank\">ZUO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428575-zuoraminus-4-goldman-says-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zuora -4% as Goldman says Sell</a></h4><ul><li>Goldman Sachs reinstates its Zuora (NYSE:<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a>) coverage with a Sell rating and $18 target, a 17% downside.</li><li>Zuora is expected to report earnings on March 7. Consensus <a href=\"https://seekingalpha.com/symbol/ZUO/earnings\" target=\"_blank\">estimates</a> put revenue at $63M with a loss per share of $0.11.</li><li>Zuora is <font color=\"red\">down 4.1%</font> premarket to $20.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428575\" data-linked=\"Zuora -4% as Goldman says Sell\" data-tweet=\"$ZUO - Zuora -4% as Goldman says Sell https://seekingalpha.com/news/3428575-zuoraminus-4-goldman-says-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3428575-zuoraminus-4-goldman-says-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428573\" data-ts=\"1549025219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYB\" target=\"_blank\">LYB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428573-lyondellbasselminus-3-after-big-misses-on-q4-earnings-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LyondellBassel -3% after big misses on Q4 earnings, revenues</a></h4><ul><li>LyondellBasell (NYSE:<a href='https://seekingalpha.com/symbol/LYB' title='LyondellBasell Industries N.V.'>LYB</a>) <font color=\"red\">-3.1%</font> pre-market after posting wide misses for both <a href=\"https://seekingalpha.com/news/3428519-lyondellbasell-misses-0_57-misses-revenue\" target=\"_blank\">Q4 earnings</a> and revenues, hurt by weaker crude oil prices and a difficult refining market.</li><li>LYB says it non-U.S. Olefins and Polyolefins business was hurt by weaker demand as customers delayed orders and destocked inventories in expectations of lower pricing, which compounded the effects of typical Q4 seasonality, as well as reduced automotive demand, low water levels on  the Rhine River, extended maintenance at its Wesseling, Germany cracker and feedstock supply constraints at the Münchsmünster, Germany cracker.</li><li>LYB says Q4 refining margins were pressured by high U.S. gasoline inventories and unusually weak discounts for Maya crude oil.</li><li>But the company says it is well positioned to capture the benefits of expected refining market improvements with no planned maintenance at its refinery in 2019 or 2020.</li><li>LYB also says it is seeing normalization of markets during the early weeks of this year, with increased polymer demand and modest improvements in the discount for Maya crude oil.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428573\" data-linked=\"LyondellBassel -3% after big misses on Q4 earnings, revenues\" data-tweet=\"$LYB - LyondellBassel -3% after big misses on Q4 earnings, revenues https://seekingalpha.com/news/3428573-lyondellbasselminus-3-after-big-misses-on-q4-earnings-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3428573-lyondellbasselminus-3-after-big-misses-on-q4-earnings-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428571\" data-ts=\"1549025146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVEO\" target=\"_blank\">AVEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428571-cantor-softens-view-on-corcept-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cantor softens view on Corcept in premarket analyst action</a></h4><ul><li>AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) downgraded to Neutral with a $1 (43% upside) price target at H.C. Wainwright after delay in Fotivda NDA filing. Shares up <font color=\"green\">2% </font>premarket.</li><li>Corcept Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CORT' title='Corcept Therapeutics Incorporated'>CORT</a>) downgraded to Neutral with a $14 (25% upside) price target at Cantor Fitzgerald after it released preliminary Q4 results.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428571\" data-linked=\"Cantor softens view on Corcept in premarket analyst action\" data-tweet=\"$AVEO $AVEO $CORT - Cantor softens view on Corcept in premarket analyst action https://seekingalpha.com/news/3428571-cantor-softens-view-on-corcept-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3428571-cantor-softens-view-on-corcept-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428569\" data-ts=\"1549024932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROP\" target=\"_blank\">ROP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428569-roperplus-2-on-q4-beats-upside-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roper +2% on Q4 beats, upside guide</a></h4><ul><li>Roper (NYSE:<a href='https://seekingalpha.com/symbol/ROP' title='Roper Technologies, Inc.'>ROP</a>) <font color=\"green\">gains 2.3%</font> premarket on Q4 beats with revenue up 12% Y/Y. Upside Q1 guidance has EPS of $2.74 to $2.80 (consensus: $2.73). In-line FY19 guidance has EPS of $12 to $12.40 (consensus: $12.23).</li><li>Earnings call started at 7:30 AM ET with a webcast available <a href=\"http://www.ropertech.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17398792-roper-technologies-announces-record-2018-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428503-roper-beats-0_09-beats-revenue\" target=\"_blank\">Roper beats by $0.09, beats on revenue</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428569\" data-linked=\"Roper +2% on Q4 beats, upside guide\" data-tweet=\"$ROP - Roper +2% on Q4 beats, upside guide https://seekingalpha.com/news/3428569-roperplus-2-on-q4-beats-upside-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3428569-roperplus-2-on-q4-beats-upside-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428567\" data-ts=\"1549024517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOHU\" target=\"_blank\">SOHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428567-sohuplus-3-on-mixed-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sohu +3% on mixed Q4</a></h4><ul><li>Sohu (NASDAQ:<a href='https://seekingalpha.com/symbol/SOHU' title='Sohu.com Limited'>SOHU</a>) <font color=\"green\">gains 2.9%</font> premarket after Q4 results that beat revenue estimates but missed on EPS. Q1 guidance has revenue from $390M to $415M (single analyst estimate: $444M) and loss per share of $1.55 to $1.30 (single analyst: -$1.33).</li><li>Q4 loss attributable to shareholders was $59M compared to the $78M in last year's quarter.</li><li>Revenue breakdown: Brand advertising, $57M (-20% Y/Y); Search and search related advertising, $277M (+12% Y/Y); Online game, $94M (-14% Y/Y).</li><li>Earnings call is scheduled for 8:30 AM ET with a webcast available <a href=\"http://investors.sohu.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17398723-sohu-com-reports-fourth-quarter-fiscal-year-2018-unaudited-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3428480-sohu-com-misses-0_18-beats-revenue\" target=\"_blank\">Sohu.com misses by $0.18, beats on revenue</a> (Feb. 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3428567\" data-linked=\"Sohu +3% on mixed Q4\" data-tweet=\"$SOHU - Sohu +3% on mixed Q4 https://seekingalpha.com/news/3428567-sohuplus-3-on-mixed-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3428567-sohuplus-3-on-mixed-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428565\" data-ts=\"1549024411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVTR\" target=\"_blank\">NVTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428565-new-chief-nuvectra-shares-down-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New chief at Nuvectra; shares down 7% premarket</a></h4><ul><li>Nuvectra (NASDAQ:<a href='https://seekingalpha.com/symbol/NVTR' title='Nuvectra Corporation'>NVTR</a>) <a href=\"https://seekingalpha.com/pr/17398556-nuvectra-appoints-dr-fred-b-parks-chief-executive-officer\" target=\"_blank\">appoints </a>board member Fred Parks, Ph.D. as CEO effective immediately. He succeeds Scott Drees who stepped down for undisclosed reasons.</li><li>Shares are down <font color=\"red\">7%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428565\" data-linked=\"New chief at Nuvectra; shares down 7% premarket\" data-tweet=\"$NVTR - New chief at Nuvectra; shares down 7% premarket https://seekingalpha.com/news/3428565-new-chief-nuvectra-shares-down-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3428565-new-chief-nuvectra-shares-down-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428563\" data-ts=\"1549024385\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HON\" target=\"_blank\">HON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428563-honeywellplus-1_7-on-q4-beat-seeing-strong-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Honeywell +1.7% on Q4 beat, seeing strong 2019</a></h4><ul><li>Earnings per share (excluding the impact of the spin-offs completed in 2018) were $1.91, up 12% Y/Y.</li><li>Sales by segment: Aerospace +10%; Home and Building Technologies +1%; Performance Materials and Technologies flat; Safety and Productivity Solutions +15%.</li><li>\"Expect strong sales, margin and cash flow growth in 2019 following portfolio transformation,\" reads a company <a href=\"https://seekingalpha.com/pr/17398833-honeywell-reports-strong-finish-2018-expects-2019-earnings-per-share-7_80-8_10\" target=\"_blank\">press release</a>.</li><li>Outlook for 2019: Earnings per share of $7.80-$8.10, on sales of $36B-$36.9B (representing organic sales growth of 2%-5%).</li><li>Conference call <a href=\"https://honeywell.webcasts.com/starthere.jsp?ei=1224666&amp;tp_key=e651cf5fa3\" target=\"_blank\">here</a> at 8:30 a.m. ET.</li><li><a href='https://seekingalpha.com/symbol/HON' title='Honeywell International, Inc.'>HON</a> <font color=\"green\">+1.7%</font> premarket</li><li><a href=\"https://seekingalpha.com/news/3428516-honeywell-beats-0_02-beats-revenue\" target=\"_blank\">Q4 results</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3428563\" data-linked=\"Honeywell +1.7% on Q4 beat, seeing strong 2019\" data-tweet=\"$HON - Honeywell +1.7% on Q4 beat, seeing strong 2019 https://seekingalpha.com/news/3428563-honeywellplus-1_7-on-q4-beat-seeing-strong-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3428563-honeywellplus-1_7-on-q4-beat-seeing-strong-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3428559\" data-ts=\"1549024131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3428559-teck-resources-sees-q4-earnings-far-below-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck Resources sees Q4 earnings far below expectations</a></h4><ul><li>Teck Resources (NYSE:<a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a>) <font color=\"red\">-8%</font> pre-market after saying it expects Q4 earnings to come in <a href=\"https://seekingalpha.com/pr/17398713-teck-fourth-quarter-2018-financial-results-expected-current-consensus-estimates\" target=\"_blank\">\"significantly below\" market estimates</a>, hurt mainly by disappointing results at its energy unit and Trail operations.</li><li>Teck says results at the two units, as well as inventory valuations, will reduce quarterly earnings by C$0.30/share, resulting in a C$0.15 loss for the quarter vs. <a href=\"https://www.reuters.com/article/us-teck-resources-outlook/teck-resources-warns-on-fourth-quarter-profit-idUSKCN1PQ3R5\" target=\"_blank\">analyst consensus C$1.10 gain</a>, and a C$195M reduction in Q4 EBITDA.</li><li>Teck says the \"dramatic widening\" of heavy oil differentials hurt results at its Energy Business unit, while Trail Operations continued to process low-grade lead concentrates due to ongoing interruptions of supply from some traditional third party suppliers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3428559\" data-linked=\"Teck Resources sees Q4 earnings far below expectations\" data-tweet=\"$TECK - Teck Resources sees Q4 earnings far below expectations https://seekingalpha.com/news/3428559-teck-resources-sees-q4-earnings-far-below-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3428559-teck-resources-sees-q4-earnings-far-below-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}